{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:51:10Z","timestamp":1795132270758,"version":"4.10.3"},"reference-count":692,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic neuropathy (DN) is a prevalent and debilitating complication of diabetes mellitus, significantly impacting patient quality of life and contributing to morbidity and mortality. Affecting approximately 50% of patients with diabetes, DN is predominantly characterized by distal symmetric polyneuropathy, leading to sensory loss, pain, and motor dysfunction, often resulting in diabetic foot ulcers and lower-limb amputations. The pathogenesis of DN is multifaceted, involving hyperglycemia, dyslipidemia, oxidative stress, mitochondrial dysfunction, and inflammation, which collectively damage peripheral nerves. Despite extensive research, disease-modifying treatments remain elusive, with current management primarily focusing on symptom control. This review explores the complex mechanisms underlying DN and highlights recent advances in diagnostic and therapeutic strategies. Emerging insights into the molecular and cellular pathways have unveiled potential targets for intervention, including neuroprotective agents, gene and stem cell therapies, and innovative pharmacological approaches. Additionally, novel diagnostic tools, such as corneal confocal microscopy and biomarker-based tests, have improved early detection and intervention. Lifestyle modifications and multidisciplinary care strategies can enhance patient outcomes. While significant progress has been made, further research is required to develop therapies that can effectively halt or reverse disease progression, ultimately improving the lives of individuals with DN. This review provides a comprehensive overview of current understanding and future directions in DN research and management.<\/jats:p>","DOI":"10.1038\/s41392-025-02175-1","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T19:01:39Z","timestamp":1745521299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":266,"title":["Diabetic neuropathy: cutting-edge research and future directions"],"prefix":"10.1038","volume":"10","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2044-3074","authenticated-orcid":false,"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","volume":"17","author":"G Sloan","year":"2021","unstructured":"Sloan, G., Selvarajah, D. & Tesfaye, S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat. Rev. Endocrinol. 17, 400\u2013420 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2175_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory, G. A. et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: s modelling study. Lancet Diabetes Endocrinol. 10, 741\u2013760 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2175_CR3","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman, E. L. et al. Diabetic neuropathy. Nat. Rev. Dis. Prim. 5, 42 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2175_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui, R. et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40, 136\u2013154 (2017).","journal-title":"Diabetes Care"},{"key":"2175_CR6","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong, D. G., Boulton, A. J. M. & Bus, S. A. Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 376, 2367\u20132375 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2175_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","volume":"14","author":"L Ang","year":"2014","unstructured":"Ang, L., Jaiswal, M., Martin, C. & Pop-Busui, R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr. Diabetes Rep. 14, 528 (2014).","journal-title":"Curr. Diabetes Rep."},{"key":"2175_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks, C. W. & Selvin, E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr. Diabetes Rep. 19, 86 (2019).","journal-title":"Curr. Diabetes Rep."},{"key":"2175_CR9","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","volume":"833","author":"S Dewanjee","year":"2018","unstructured":"Dewanjee, S. et al. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur. J. Pharmacol. 833, 472\u2013523 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"2175_CR11","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.neuron.2023.05.003","volume":"111","author":"SA Eid","year":"2023","unstructured":"Eid, S. A. et al. New perspectives in diabetic neuropathy. Neuron 111, 2623\u20132641 (2023).","journal-title":"Neuron"},{"key":"2175_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/er.2018-00107","volume":"40","author":"GJ B\u00f6nhof","year":"2019","unstructured":"B\u00f6nhof, G. J. et al. Emerging biomarkers, tools, and treatments for diabetic polyneuropathy. Endocr. Rev. 40, 153\u2013192 (2019).","journal-title":"Endocr. Rev."},{"key":"2175_CR13","doi-asserted-by":"publisher","first-page":"9524635","DOI":"10.1155\/2020\/9524635","volume":"2020","author":"L Pang","year":"2020","unstructured":"Pang, L. et al. Understanding diabetic neuropathy: Focus on oxidative stress. Oxid. Med. Cell. Longev. 2020, 9524635 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2175_CR14","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.3390\/ijms25158126","volume":"25","author":"S Ye","year":"2024","unstructured":"Ye, S., Cheng, Z. L., Zhuo, D. Y. & Liu, S. M. Different types of cell death in diabetic neuropathy: a focus on mechanisms and therapeutic strategies. Int. J. Mol. Sci. 25, 8126 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman, E. L., Nave, K. A., Jensen, T. S. & Bennett, D. L. H. New horizons in diabetic neuropathy: Mechanisms, bioenergetics, and pain. Neuron 93, 1296\u20131313 (2017).","journal-title":"Neuron"},{"key":"2175_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-015-0671-9","volume":"15","author":"P Fernyhough","year":"2015","unstructured":"Fernyhough, P. Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events. Curr. Diab Rep. 15, 89 (2015).","journal-title":"Curr. Diab Rep."},{"key":"2175_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162\u2013173 (2015).","journal-title":"Lancet Neurol."},{"key":"2175_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2174\/1871527320666210303111939","volume":"21","author":"M Rafiullah","year":"2022","unstructured":"Rafiullah, M. & Siddiqui, K. Pharmacological treatment of diabetic peripheral neuropathy: an update. CNS Neurol. Disord. Drug Targets 21, 884\u2013900 (2022).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"2175_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/cxo.12887","volume":"103","author":"IN Petropoulos","year":"2020","unstructured":"Petropoulos, I. N. et al. Corneal confocal microscopy: ready for prime time. Clin. Exp. Optom. 103, 265\u2013277 (2020).","journal-title":"Clin. Exp. Optom."},{"key":"2175_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/NEN.0b013e3182580673","volume":"71","author":"M Kan","year":"2012","unstructured":"Kan, M., Guo, G. F., Singh, B., Singh, V. & Zochodne, D. W. Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy. J. Neuropathol. Exp. Neurol. 71, 494\u2013510 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2175_CR21","doi-asserted-by":"publisher","first-page":"10848","DOI":"10.1021\/acs.jmedchem.2c00867","volume":"65","author":"R Maccari","year":"2022","unstructured":"Maccari, R. & Ottan\u00e0, R. Sodium-glucose cotransporter inhibitors as antidiabetic drugs: current development and future perspectives. J. Med. Chem. 65, 10848\u201310881 (2022).","journal-title":"J. Med. Chem."},{"key":"2175_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","volume":"26","author":"PM Kluding","year":"2012","unstructured":"Kluding, P. M. et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J. Diabetes Complicat. 26, 424\u2013429 (2012).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40265-020-01259-2","volume":"80","author":"U Alam","year":"2020","unstructured":"Alam, U., Sloan, G. & Tesfaye, S. Treating pain in diabetic neuropathy: current and developmental drugs. Drugs 80, 363\u2013384 (2020).","journal-title":"Drugs"},{"key":"2175_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators.","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402, 203\u2013234 (2023).","journal-title":"Lancet"},{"key":"2175_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-53480-4.00001-1","volume":"126","author":"D Ziegler","year":"2014","unstructured":"Ziegler, D., Papanas, N., Vinik, A. I. & Shaw, J. E. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb. Clin. Neurol. 126, 3\u201322 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.2337\/dc19-1614","volume":"43","author":"YQ Zhang","year":"2020","unstructured":"Zhang, Y. Q. et al. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 43, 964\u2013974 (2020).","journal-title":"Diabetes Care"},{"key":"2175_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3702","volume":"39","author":"WM Wang","year":"2023","unstructured":"Wang, W. M. et al. Prevalence and risk factors of diabetic peripheral neuropathy: a population-based cross-sectional study in China. Diabetes Metab. Res. Rev. 39, e3702 (2023).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2337\/dc07-1796","volume":"31","author":"D Ziegler","year":"2008","unstructured":"Ziegler, D., Rathmann, W., Dickhaus, T., Meisinger, C. & Mielck, A. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3. Diabetes Care 31, 464\u2013469 (2008).","journal-title":"Diabetes Care"},{"key":"2175_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2337\/dc19-1582","volume":"43","author":"A Jeyam","year":"2020","unstructured":"Jeyam, A. et al. Diabetic neuropathy is a substantial burden in people with type 1 diabetes and is strongly associated with socioeconomic disadvantage: a population-representative study from Scotland. Diabetes Care 43, 734\u2013742 (2020).","journal-title":"Diabetes Care"},{"key":"2175_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2337\/dc19-1583","volume":"43","author":"KR Mizokami-Stout","year":"2020","unstructured":"Mizokami-Stout, K. R. et al. The contemporary prevalence of diabetic neuropathy in type 1 diabetes: findings from the T1D exchange. Diabetes Care 43, 806\u2013812 (2020).","journal-title":"Diabetes Care"},{"key":"2175_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k, A. G., Herder, C., Rathmann, W., Brunner, E. J. & Kivim\u00e4ki, M. Prediabetes: a high-risk state for diabetes development. Lancet 379, 2279\u20132290 (2012).","journal-title":"Lancet"},{"key":"2175_CR32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s001250050586","volume":"39","author":"S Tesfaye","year":"1996","unstructured":"Tesfaye, S. et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 39, 1377\u20131384 (1996).","journal-title":"Diabetologia"},{"key":"2175_CR33","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/db19-1046","volume":"69","author":"BH Braffett","year":"2020","unstructured":"Braffett, B. H. et al. Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study. Diabetes 69, 1000\u20131010 (2020).","journal-title":"Diabetes"},{"key":"2175_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4093\/dmj.2017.0090","volume":"42","author":"JH Park","year":"2018","unstructured":"Park, J. H. & Kim, D. S. The necessity of the simple tests for diabetic peripheral neuropathy in type 2 diabetes mellitus patients without neuropathic symptoms in clinical practice. Diabetes Metab. J. 42, 442\u2013446 (2018).","journal-title":"Diabetes Metab. J."},{"key":"2175_CR35","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2337\/dc17-0179","volume":"40","author":"M Jaiswal","year":"2017","unstructured":"Jaiswal, M. et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: search for diabetes in youth study. Diabetes Care 40, 1226\u20131232 (2017).","journal-title":"Diabetes Care"},{"key":"2175_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10286-019-00607-x","volume":"29","author":"LA Zilliox","year":"2019","unstructured":"Zilliox, L. A. & Russell, J. W. Physical activity and dietary interventions in diabetic neuropathy: a systematic review. Clin. Auton. Res. 29, 443\u2013455 (2019).","journal-title":"Clin. Auton. Res."},{"key":"2175_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41582-022-00741-7","volume":"19","author":"R Baron","year":"2023","unstructured":"Baron, R., Dickenson, A. H., Calvo, M., Dib-Hajj, S. D. & Bennett, D. L. Maximizing treatment efficacy through patient stratification in neuropathic pain trials. Nat. Rev. Neurol. 19, 53\u201364 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR38","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2337\/dc11-1108","volume":"34","author":"CA Abbott","year":"2011","unstructured":"Abbott, C. A., Malik, R. A., van Ross, E. R., Kulkarni, J. & Boulton, A. J. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 34, 2220\u20132224 (2011).","journal-title":"Diabetes Care"},{"key":"2175_CR39","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1097\/j.pain.0000000000001378","volume":"159","author":"A Truini","year":"2018","unstructured":"Truini, A. et al. A cross-sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy. Pain 159, 2658\u20132666 (2018).","journal-title":"Pain"},{"key":"2175_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1526-4637.2008.00555.x","volume":"10","author":"D Ziegler","year":"2009","unstructured":"Ziegler, D., Rathmann, W., Dickhaus, T., Meisinger, C. & Mielck, A. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA\/KORA Augsburg Surveys S2 and S3. Pain Med. 10, 393\u2013400 (2009).","journal-title":"Pain Med."},{"key":"2175_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev-med-043021-033114","volume":"75","author":"BR Dillon","year":"2024","unstructured":"Dillon, B. R., Ang, L. & Pop-Busui, R. Spectrum of diabetic neuropathy: new insights in diagnosis and treatment. Annu. Rev. Med. 75, 293\u2013306 (2024).","journal-title":"Annu. Rev. Med."},{"key":"2175_CR42","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye, S. et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285\u20132293 (2010).","journal-title":"Diabetes Care"},{"key":"2175_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","volume":"14","author":"XX Liu","year":"2019","unstructured":"Liu, X. X., Xu, Y. Y., An, M. M. & Zeng, Q. B. The risk factors for diabetic peripheral neuropathy: a meta-analysis. PLoS ONE 14, e0212574 (2019).","journal-title":"PLoS ONE"},{"key":"2175_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L. & Feldman, E. L. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 11, 521\u2013534 (2012).","journal-title":"Lancet Neurol."},{"key":"2175_CR45","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41591-024-03123-2","volume":"30","author":"EW Gregg","year":"2024","unstructured":"Gregg, E. W. et al. The burden of diabetes-associated multiple long-term conditions on years of life spent and lost. Nat. Med. 30, 2830\u20132837 (2024).","journal-title":"Nat. Med."},{"key":"2175_CR46","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.2337\/dc20-2241","volume":"44","author":"N den Braber","year":"2021","unstructured":"den Braber, N. et al. Glucose regulation beyond HbA1c in type 2 diabetes treated with insulin: real-world evidence from the DIALECT-2 cohort. Diabetes Care 44, 2238\u20132244 (2021).","journal-title":"Diabetes Care"},{"key":"2175_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","volume":"5","author":"S Zoungas","year":"2017","unstructured":"Zoungas, S. et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 5, 431\u2013437 (2017).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2175_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1377923","volume":"15","author":"CS Wang","year":"2024","unstructured":"Wang, C. S. et al. Diabetic peripheral neuropathy: age-stratified glycemic control. Front. Endocrinol. (Lausanne) 15, 1377923 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2175_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrneurol.2017.181","volume":"14","author":"S Starling","year":"2018","unstructured":"Starling, S. Ageing: somatic mutations accumulate in ageing and diseased neurons. Nat. Rev. Neurol. 14, 64 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd2476","volume":"8","author":"NA Calcutt","year":"2009","unstructured":"Calcutt, N. A., Cooper, M. E., Kern, T. S. & Schmidt, A. M. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat. Rev. Drug Discov. 8, 417\u2013429 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2175_CR51","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","volume":"73","author":"BC Callaghan","year":"2016","unstructured":"Callaghan, B. C. et al. Association between metabolic syndrome components and polyneuropathy in an obese population. JAMA Neurol. 73, 1468\u20131476 (2016).","journal-title":"JAMA Neurol."},{"key":"2175_CR52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","volume":"27","author":"AG Smith","year":"2013","unstructured":"Smith, A. G. & Singleton, J. R. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. J. Diabetes Complicat. 27, 436\u2013442 (2013).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1096\/fj.201700206R","volume":"32","author":"AE Rumora","year":"2018","unstructured":"Rumora, A. E. et al. Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons. FASEB J. 32, 195\u2013207 (2018).","journal-title":"FASEB J."},{"key":"2175_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","volume":"7","author":"AM Vincent","year":"2011","unstructured":"Vincent, A. M., Callaghan, B. C., Smith, A. L. & Feldman, E. L. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat. Rev. Neurol. 7, 573\u2013583 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR55","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/jdi.12794","volume":"9","author":"HY Jin","year":"2018","unstructured":"Jin, H. Y. & Park, T. S. Role of inflammatory biomarkers in diabetic peripheral neuropathy. J. Diabetes Investig. 9, 1016\u20131018 (2018).","journal-title":"J. Diabetes Investig."},{"key":"2175_CR56","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11606-015-3354-y","volume":"30","author":"C Clair","year":"2015","unstructured":"Clair, C., Cohen, M. J., Eichler, F., Selby, K. J. & Rigotti, N. A. The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J. Gen. Intern. Med. 30, 1193\u20131203 (2015).","journal-title":"J. Gen. Intern. Med."},{"key":"2175_CR57","doi-asserted-by":"publisher","first-page":"e3099","DOI":"10.1002\/dmrr.3099","volume":"35","author":"Y Gu","year":"2019","unstructured":"Gu, Y., Dennis, S. M., Kiernan, M. C. & Harmer, A. R. Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: a systematic review. Diabetes Metab. Res. Rev. 35, e3099 (2019).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR58","doi-asserted-by":"publisher","first-page":"e1783","DOI":"10.1097\/MD.0000000000001783","volume":"94","author":"CP Yang","year":"2015","unstructured":"Yang, C. P. et al. Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: the Taiwan diabetes study. Medicine 94, e1783 (2015).","journal-title":"Medicine"},{"key":"2175_CR59","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3390\/ijms22094887","volume":"22","author":"M Jankovic","year":"2021","unstructured":"Jankovic, M. et al. Genetic and epigenomic modifiers of diabetic neuropathy. Int. J. Mol. Sci. 22, 4887 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR60","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505\u20131513 (2018).","journal-title":"Nat. Genet."},{"key":"2175_CR61","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/13813455.2020.1837183","volume":"129","author":"KM Adki","year":"2023","unstructured":"Adki, K. M. & Kulkarni, Y. A. Biomarkers in diabetic neuropathy. Arch. Physiol. Biochem. 129, 460\u2013475 (2023).","journal-title":"Arch. Physiol. Biochem."},{"key":"2175_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharep.2017.04.017","volume":"70","author":"A Kakavand Hamidi","year":"2018","unstructured":"Kakavand Hamidi, A., Radfar, M. & Amoli, M. M. Association between MTHFR variant and diabetic neuropathy. Pharmacol. Rep. 70, 1\u20135 (2018).","journal-title":"Pharmacol. Rep."},{"key":"2175_CR63","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/ijms25031815","volume":"25","author":"DZ Tordai","year":"2024","unstructured":"Tordai, D. Z. et al. Genetic factors associated with the development of neuropathy in type 2 diabetes. Int. J. Mol. Sci. 25, 1815 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0905-3","volume":"17","author":"K Zitouni","year":"2017","unstructured":"Zitouni, K., Tinworth, L. & Earle, K. A. Ethnic differences in the +405 and -460 vascular endothelial growth factor polymorphisms and peripheral neuropathy in patients with diabetes residing in a North London, community in the United Kingdom. BMC Neurol. 17, 125 (2017).","journal-title":"BMC Neurol."},{"key":"2175_CR65","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","volume":"8","author":"M Apicella","year":"2020","unstructured":"Apicella, M. et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 8, 782\u2013792 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2175_CR66","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","volume":"19","author":"MA Ellul","year":"2020","unstructured":"Ellul, M. A. et al. Neurological associations of COVID-19. Lancet Neurol. 19, 767\u2013783 (2020).","journal-title":"Lancet Neurol."},{"key":"2175_CR67","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"CM Romero-S\u00e1nchez","year":"2020","unstructured":"Romero-S\u00e1nchez, C. M. et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95, e1060\u2013e1070 (2020).","journal-title":"Neurology"},{"key":"2175_CR68","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/j.pain.0000000000000785","volume":"158","author":"HL H\u00e9bert","year":"2017","unstructured":"H\u00e9bert, H. L., Veluchamy, A., Torrance, N. & Smith, B. H. Risk factors for neuropathic pain in diabetes mellitus. Pain 158, 560\u2013568 (2017).","journal-title":"Pain"},{"key":"2175_CR69","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1097\/j.pain.0000000000001034","volume":"158","author":"J Raputova","year":"2017","unstructured":"Raputova, J. et al. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study. Pain 158, 2340\u20132353 (2017).","journal-title":"Pain"},{"key":"2175_CR70","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/j.pain.0000000000000491","volume":"157","author":"AC Themistocleous","year":"2016","unstructured":"Themistocleous, A. C. et al. The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain 157, 1132\u20131145 (2016).","journal-title":"Pain"},{"key":"2175_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.diabres.2018.02.043","volume":"139","author":"D Ziegler","year":"2018","unstructured":"Ziegler, D. et al. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Res. Clin. Pract. 139, 147\u2013154 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR72","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.2337\/dc20-2797","volume":"44","author":"A Worthington","year":"2021","unstructured":"Worthington, A. et al. Spinal inhibitory dysfunction in patients with painful or painless diabetic neuropathy. Diabetes Care 44, 1835\u20131841 (2021).","journal-title":"Diabetes Care"},{"key":"2175_CR73","doi-asserted-by":"publisher","first-page":"109928","DOI":"10.1016\/j.diabres.2022.109928","volume":"188","author":"JM Hagedorn","year":"2022","unstructured":"Hagedorn, J. M. et al. An overview of painful diabetic peripheral neuropathy: diagnosis and treatment advancements. Diabetes Res. Clin. Pract. 188, 109928 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR74","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/jdi.13388","volume":"12","author":"G Ponirakis","year":"2021","unstructured":"Ponirakis, G. et al. Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar. J. Diabetes Investig. 12, 592\u2013600 (2021).","journal-title":"J. Diabetes Investig."},{"key":"2175_CR75","doi-asserted-by":"publisher","DOI":"10.1177\/1744806919849802","volume":"15","author":"M Alsaloum","year":"2019","unstructured":"Alsaloum, M. et al. A gain-of-function sodium channel \u03b22-subunit mutation in painful diabetic neuropathy. Mol. Pain 15, 1744806919849802 (2019).","journal-title":"Mol. Pain"},{"key":"2175_CR76","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/j.pain.0000000000001116","volume":"159","author":"I Blesneac","year":"2018","unstructured":"Blesneac, I. et al. Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy. Pain 159, 469\u2013480 (2018).","journal-title":"Pain"},{"key":"2175_CR77","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ebiom.2015.08.001","volume":"2","author":"WH Meng","year":"2015","unstructured":"Meng, W. H. et al. A genome-wide association study provides evidence of sex-specific involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) with diabetic neuropathic pain. EBioMedicine 2, 1386\u20131393 (2015).","journal-title":"EBioMedicine"},{"key":"2175_CR78","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ejp.560","volume":"19","author":"W Meng","year":"2015","unstructured":"Meng, W. et al. A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain. Eur. J. Pain 19, 392\u2013399 (2015).","journal-title":"Eur. J. Pain"},{"key":"2175_CR79","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.2337\/dc19-S011","volume":"42","author":"American Diabetes Association.","year":"2019","unstructured":"American Diabetes Association. 11. Microvascular complications and foot care: Standards of Medical Care in Diabetes-2019. Diabetes Care 42, S124\u2013S138 (2019).","journal-title":"Diabetes Care"},{"key":"2175_CR80","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1093\/brain\/awz333","volume":"142","author":"G Devigili","year":"2019","unstructured":"Devigili, G. et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain 142, 3728\u20133736 (2019).","journal-title":"Brain"},{"key":"2175_CR81","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bja\/aex175","volume":"119","author":"MR Mulvey","year":"2017","unstructured":"Mulvey, M. R. et al. Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles. Br. J. Anaesth. 119, 765\u2013774 (2017).","journal-title":"Br. J. Anaesth."},{"key":"2175_CR82","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup, N. B., Kuner, R. & Jensen, T. S. Neuropathic pain: from mechanisms to treatment. Physiol. Rev. 101, 259\u2013301 (2021).","journal-title":"Physiol. Rev."},{"key":"2175_CR83","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/SPC.0b013e32832b7df5","volume":"3","author":"S Tesfaye","year":"2009","unstructured":"Tesfaye, S. Advances in the management of diabetic peripheral neuropathy. Curr. Opin. Support. Palliat. Care 3, 136\u2013143 (2009).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"2175_CR84","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron, R., Binder, A. & Wasner, G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 9, 807\u2013819 (2010).","journal-title":"Lancet Neurol."},{"key":"2175_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11916-011-0181-7","volume":"15","author":"A Hovaguimian","year":"2011","unstructured":"Hovaguimian, A. & Gibbons, C. H. Diagnosis and treatment of pain in small-fiber neuropathy. Curr. Pain Headache Rep. 15, 193\u2013200 (2011).","journal-title":"Curr. Pain Headache Rep."},{"key":"2175_CR86","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/mus.23859","volume":"48","author":"SA Boruchow","year":"2013","unstructured":"Boruchow, S. A. & Gibbons, C. H. Utility of skin biopsy in management of small fiber neuropathy. Muscle Nerve 48, 877\u2013882 (2013).","journal-title":"Muscle Nerve"},{"key":"2175_CR87","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"G Lauria","year":"2010","unstructured":"Lauria, G. et al. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur. J. Neurol. 17, 903\u2013912, e944-9 (2010).","journal-title":"Eur. J. Neurol."},{"key":"2175_CR88","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jpain.2022.01.002","volume":"23","author":"J R\u00f8ikjer","year":"2022","unstructured":"R\u00f8ikjer, J. et al. The histamine-induced axon-reflex response in people with type 1 diabetes with and without peripheral neuropathy and pain: a clinical, observational study. J. Pain 23, 1167\u20131176 (2022).","journal-title":"J. Pain"},{"key":"2175_CR89","first-page":"Cd010975","volume":"2018","author":"ZR Yang","year":"2018","unstructured":"Yang, Z. R. et al. Simple tests to screen for diabetic peripheral neuropathy. Cochrane Database Syst. Rev. 2018, Cd010975 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR90","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ecl.2013.06.001","volume":"42","author":"AI Vinik","year":"2013","unstructured":"Vinik, A. I., Nevoret, M. L., Casellini, C. & Parson, H. Diabetic neuropathy. Endocrinol. Metab. Clin. North Am. 42, 747\u2013787 (2013).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2175_CR91","doi-asserted-by":"publisher","first-page":"633915","DOI":"10.3389\/fnsys.2021.633915","volume":"15","author":"Q Cai","year":"2021","unstructured":"Cai, Q. et al. The physiological significance of A-waves in early diabetic neuropathy: assessment of motor nerve fibers by neurophysiological techniques. Front. Syst. Neurosci. 15, 633915 (2021).","journal-title":"Front. Syst. Neurosci."},{"key":"2175_CR92","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/dmrr.2319","volume":"28","author":"M Monteiro-Soares","year":"2012","unstructured":"Monteiro-Soares, M., Boyko, E. J., Ribeiro, J., Ribeiro, I. & Dinis-Ribeiro, M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab. Res. Rev. 28, 574\u2013600 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PHM.0000000000000604","volume":"96","author":"JK Richardson","year":"2017","unstructured":"Richardson, J. K., Eckner, J. T., Allet, L., Kim, H. & Ashton-Miller, J. A. Complex and simple clinical reaction times are associated with gait, balance, and major fall injury in older subjects with diabetic peripheral neuropathy. Am. J. Phys. Med. Rehabil. 96, 8\u201316 (2017).","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"2175_CR94","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ana.25182","volume":"83","author":"JME Jende","year":"2018","unstructured":"Jende, J. M. E. et al. Diabetic neuropathy differs between type 1 and type 2 diabetes: insights from magnetic resonance neurography. Ann. Neurol. 83, 588\u2013598 (2018).","journal-title":"Ann. Neurol."},{"key":"2175_CR95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4239\/wjd.v6.i1.37","volume":"6","author":"L Yazdanpanah","year":"2015","unstructured":"Yazdanpanah, L., Nasiri, M. & Adarvishi, S. Literature review on the management of diabetic foot ulcer. World J. Diabetes 6, 37\u201353 (2015).","journal-title":"World J. Diabetes"},{"key":"2175_CR96","doi-asserted-by":"publisher","first-page":"e3746","DOI":"10.1002\/dmrr.3746","volume":"40","author":"A Drovandi","year":"2024","unstructured":"Drovandi, A., Seng, L. & Golledge, J. Effectiveness of educational interventions for diabetes-related foot disease: a systematic review and meta-analysis. Diabetes Metab. Res. Rev. 40, e3746 (2024).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR97","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/ene.13533","volume":"25","author":"A Abraham","year":"2018","unstructured":"Abraham, A. et al. Toronto Clinical Neuropathy Score is valid for a wide spectrum of polyneuropathies. Eur. J. Neurol. 25, 484\u2013490 (2018).","journal-title":"Eur. J. Neurol."},{"key":"2175_CR98","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/jcm9051487","volume":"9","author":"R Fern\u00e1ndez-Torres","year":"2020","unstructured":"Fern\u00e1ndez-Torres, R., Ruiz-Mu\u00f1oz, M., P\u00e9rez-Panero, A. J., Garc\u00eda-Romero, J. C. & G\u00f3nzalez-S\u00e1nchez, M. Clinician assessment tools for patients with diabetic foot disease: a systematic review. J. Clin. Med. 9, 1487 (2020).","journal-title":"J. Clin. Med."},{"key":"2175_CR99","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"WH Herman","year":"2012","unstructured":"Herman, W. H. et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications. Diabet. Med. 29, 937\u2013944 (2012).","journal-title":"Diabet. Med."},{"key":"2175_CR100","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/brain\/awab079","volume":"144","author":"TS Jensen","year":"2021","unstructured":"Jensen, T. S. et al. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain 144, 1632\u20131645 (2021).","journal-title":"Brain"},{"key":"2175_CR101","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","volume":"7","author":"D Selvarajah","year":"2019","unstructured":"Selvarajah, D. et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 7, 938\u2013948 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2175_CR102","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S1388-2457(03)00025-7","volume":"114","author":"BA Perkins","year":"2003","unstructured":"Perkins, B. A. & Bril, V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin. Neurophysiol. 114, 1167\u20131175 (2003).","journal-title":"Clin. Neurophysiol."},{"issue":"Suppl 1","key":"2175_CR103","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/dmrr.2706","volume":"32","author":"EJ Peters","year":"2016","unstructured":"Peters, E. J. et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diabetes Metab. Res. Rev. 32(Suppl 1), 145\u2013153 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/152091501750219994","volume":"3","author":"M Polydefkis","year":"2001","unstructured":"Polydefkis, M., Hauer, P., Griffin, J. W. & McArthur, J. C. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol. Ther. 3, 23\u201328 (2001).","journal-title":"Diabetes Technol. Ther."},{"key":"2175_CR105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pmrj.2008.11.011","volume":"1","author":"JD England","year":"2009","unstructured":"England, J. D. et al. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R. 1, 14\u201322 (2009).","journal-title":"PM R."},{"key":"2175_CR106","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/193229681300700509","volume":"7","author":"M Tavakoli","year":"2013","unstructured":"Tavakoli, M., Petropoulos, I. N. & Malik, R. A. Corneal confocal microscopy to assess diabetic neuropathy: an eye on the foot. J. Diabetes Sci. Technol. 7, 1179\u20131189 (2013).","journal-title":"J. Diabetes Sci. Technol."},{"key":"2175_CR107","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdiacomp.2014.08.008","volume":"29","author":"D Ziegler","year":"2015","unstructured":"Ziegler, D. & Fonseca, V. From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. J. Diabetes Complicat. 29, 146\u2013156 (2015).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR108","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1111\/jns.12335","volume":"24","author":"NP Staff","year":"2019","unstructured":"Staff, N. P. et al. Platinum-induced peripheral neurotoxicity: from pathogenesis to treatment. J. Peripher. Nerv. Syst. 24, S26\u2013S39 (2019).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2175_CR109","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11892-012-0278-3","volume":"12","author":"N Papanas","year":"2012","unstructured":"Papanas, N. & Ziegler, D. Prediabetic neuropathy: does it exist? Curr. Diabetes Rep. 12, 376\u2013383 (2012).","journal-title":"Curr. Diabetes Rep."},{"key":"2175_CR110","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/dmrr.2696","volume":"32","author":"SA Bus","year":"2016","unstructured":"Bus, S. A. et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes Metab. Res. Rev. 32, 16\u201324 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3273","volume":"36","author":"M Monteiro-Soares","year":"2020","unstructured":"Monteiro-Soares, M. et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab. Res. Rev. 36, e3273 (2020).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4093\/dmj.2018.0259","volume":"43","author":"V Spallone","year":"2019","unstructured":"Spallone, V. Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet. Diabetes Metab. J. 43, 3\u201330 (2019).","journal-title":"Diabetes Metab. J."},{"key":"2175_CR113","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","volume":"33","author":"T Seuring","year":"2015","unstructured":"Seuring, T., Archangelidi, O. & Suhrcke, M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics 33, 811\u2013831 (2015).","journal-title":"Pharmacoeconomics"},{"key":"2175_CR114","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3390\/ijms22052301","volume":"22","author":"Y Fujita","year":"2021","unstructured":"Fujita, Y., Murakami, T. & Nakamura, A. Recent advances in biomarkers and regenerative medicine for diabetic neuropathy. Int. J. Mol. Sci. 22, 2301 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR115","doi-asserted-by":"publisher","first-page":"5825971","DOI":"10.1155\/2017\/5825971","volume":"2017","author":"M Tavakoli","year":"2017","unstructured":"Tavakoli, M. et al. Diabetic neuropathy: current status and future prospects. J. Diabetes Res. 2017, 5825971 (2017).","journal-title":"J. Diabetes Res."},{"key":"2175_CR116","doi-asserted-by":"publisher","first-page":"S370","DOI":"10.1007\/s00592-003-0122-y","volume":"40","author":"G Jermendy","year":"2003","unstructured":"Jermendy, G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol. 40, S370\u2013S374 (2003).","journal-title":"Acta Diabetol."},{"key":"2175_CR117","doi-asserted-by":"publisher","first-page":"e0195166","DOI":"10.1371\/journal.pone.0195166","volume":"13","author":"T Benichou","year":"2018","unstructured":"Benichou, T. et al. Heart rate variability in type 2 diabetes mellitus: a systematic review and meta\u2013analysis. PLoS ONE 13, e0195166 (2018).","journal-title":"PLoS ONE"},{"key":"2175_CR118","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.clinph.2005.09.027","volume":"117","author":"R Freeman","year":"2006","unstructured":"Freeman, R. Assessment of cardiovascular autonomic function. Clin. Neurophysiol. 117, 716\u2013730 (2006).","journal-title":"Clin. Neurophysiol."},{"key":"2175_CR119","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.endonu.2015.03.012","volume":"62","author":"RC Hermida","year":"2015","unstructured":"Hermida, R. C., Moy\u00e1, A. & Ayala, D. E. Ambulatory blood pressure monitoring in diabetes for the assessment and control of vascular risk. Endocrinol. Nutr. 62, 400\u2013410 (2015).","journal-title":"Endocrinol. Nutr."},{"key":"2175_CR120","doi-asserted-by":"publisher","first-page":"AMP59","DOI":"10.1161\/circ.133.suppl_1.mp59","volume":"133","author":"SP Juraschek","year":"2016","unstructured":"Juraschek, S. P. et al. Abstract MP59: Orthostatic hypotension and risk of falls in the atherosclerosis risk in communities (ARIC) study. Circulation 133, AMP59\u2013AMP59 (2016).","journal-title":"Circulation"},{"key":"2175_CR121","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14477","volume":"30","author":"YF Cheng","year":"2024","unstructured":"Cheng, Y. F. et al. How inflammation dictates diabetic peripheral neuropathy: an enlightening review. CNS Neurosci. Ther. 30, e14477 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"2175_CR122","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1210\/er.2018-00161","volume":"40","author":"AE Bharucha","year":"2019","unstructured":"Bharucha, A. E., Kudva, Y. C. & Prichard, D. O. Diabetic gastroparesis. Endocr. Rev. 40, 1318\u20131352 (2019).","journal-title":"Endocr. Rev."},{"key":"2175_CR123","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/dc17-1536","volume":"41","author":"YT Du","year":"2018","unstructured":"Du, Y. T., Rayner, C. K., Jones, K. L., Talley, N. J. & Horowitz, M. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes Care 41, 627\u2013637 (2018).","journal-title":"Diabetes Care"},{"key":"2175_CR124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4239\/wjd.v4.i3.51","volume":"4","author":"B Krishnan","year":"2013","unstructured":"Krishnan, B., Babu, S., Walker, J., Walker, A. B. & Pappachan, J. M. Gastrointestinal complications of diabetes mellitus. World J. Diabetes 4, 51\u201363 (2013).","journal-title":"World J. Diabetes"},{"key":"2175_CR125","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4239\/wjd.v12.i9.1463","volume":"12","author":"K Alagiakrishnan","year":"2021","unstructured":"Alagiakrishnan, K. & Halverson, T. Holistic perspective of the role of gut microbes in diabetes mellitus and its management. World J. Diabetes 12, 1463\u20131478 (2021).","journal-title":"World J. Diabetes"},{"key":"2175_CR126","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MCG.0000000000000894","volume":"51","author":"NS George","year":"2017","unstructured":"George, N. S. et al. Distribution of esophageal motor disorders in diabetic patients with dysphagia. J. Clin. Gastroenterol. 51, 890\u2013895 (2017).","journal-title":"J. Clin. Gastroenterol."},{"key":"2175_CR127","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11894-016-0489-x","volume":"18","author":"RJ Saad","year":"2016","unstructured":"Saad, R. J. The wireless motility capsule: a one-stop shop for the evaluation of gi motility disorders. Curr. Gastroenterol. Rep. 18, 14 (2016).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"2175_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2967\/jnumed.112.114314","volume":"44","author":"AH Maurer","year":"2016","unstructured":"Maurer, A. H. Gastrointestinal motility, part 1: esophageal transit and gastric emptying. J. Nucl. Med. Technol. 44, 1\u201311 (2016).","journal-title":"J. Nucl. Med. Technol."},{"key":"2175_CR129","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/bph.13475","volume":"173","author":"PM Hellstr\u00f6m","year":"2016","unstructured":"Hellstr\u00f6m, P. M. et al. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying. Br. J. Pharmacol. 173, 1768\u20131777 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"2175_CR130","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/2050640614542496","volume":"2","author":"J Keller","year":"2014","unstructured":"Keller, J., Meier, V., Wolfram, K. U., Rosien, U. & Layer, P. Sensitivity and specificity of an abbreviated (13)C-mixed triglyceride breath test for measurement of pancreatic exocrine function. United Eur. Gastroenterol. J. 2, 288\u2013294 (2014).","journal-title":"United Eur. Gastroenterol. J."},{"key":"2175_CR131","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrgastro.2012.32","volume":"9","author":"JB Furness","year":"2012","unstructured":"Furness, J. B. The enteric nervous system and neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 9, 286\u2013294 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2175_CR132","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.gie.2016.06.048","volume":"85","author":"MA Khashab","year":"2017","unstructured":"Khashab, M. A. et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest. Endosc. 85, 123\u2013128 (2017).","journal-title":"Gastrointest. Endosc."},{"key":"2175_CR133","doi-asserted-by":"publisher","first-page":"108288","DOI":"10.1016\/j.jdiacomp.2022.108288","volume":"36","author":"Y Blair","year":"2022","unstructured":"Blair, Y., Wessells, H., Pop-Busui, R., Ang, L. & Sarma, A. V. Urologic complications in diabetes. J. Diabetes Complicat. 36, 108288 (2022).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR134","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.3390\/ijerph192315642","volume":"19","author":"CH Li","year":"2022","unstructured":"Li, C. H. et al. Urinary incontinence and sleep quality in older women with type 2 diabetes: a cross-sectional study. Int. J. Environ. Res. Public. Health 19, 15642 (2022).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"2175_CR135","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ijir.2016.38","volume":"29","author":"MI Maiorino","year":"2017","unstructured":"Maiorino, M. I. et al. Erectile dysfunction in young men with type 1 diabetes. Int. J. Impot. Res. 29, 17\u201322 (2017).","journal-title":"Int. J. Impot. Res."},{"key":"2175_CR136","first-page":"820","volume":"94","author":"KT Rew","year":"2016","unstructured":"Rew, K. T. & Heidelbaugh, J. J. Erectile dysfunction. Am. Fam. Physician 94, 820\u2013827 (2016).","journal-title":"Am. Fam. Physician"},{"key":"2175_CR137","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.3390\/ijerph18052536","volume":"18","author":"E B\u0105k","year":"2021","unstructured":"B\u0105k, E. et al. Sexual function and sexual quality of life in premenopausal women with controlled type 1 and 2 diabetes\u2014preliminary study. Int. J. Environ. Res. Public. Health 18, 2536 (2021).","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"2175_CR138","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2337\/diacare.25.4.672","volume":"25","author":"P Enzlin","year":"2002","unstructured":"Enzlin, P. et al. Sexual dysfunction in women with type 1 diabetes: A controlled study. Diabetes Care 25, 672\u2013677 (2002).","journal-title":"Diabetes Care"},{"key":"2175_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64339-3","volume":"14","author":"N Fujita","year":"2024","unstructured":"Fujita, N. et al. Association between sex hormones and erectile dysfunction in men without hypoandrogenism. Sci. Rep. 14, 13433 (2024).","journal-title":"Sci. Rep."},{"key":"2175_CR140","first-page":"88","volume":"5","author":"AN Shridharani","year":"2016","unstructured":"Shridharani, A. N. & Brant, W. O. The treatment of erectile dysfunction in patients with neurogenic disease. Transl. Androl. Urol. 5, 88\u2013101 (2016).","journal-title":"Transl. Androl. Urol."},{"key":"2175_CR141","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2337\/dc16-0059","volume":"39","author":"JM Hotaling","year":"2016","unstructured":"Hotaling, J. M. et al. Cardiovascular autonomic neuropathy, sexual dysfunction, and urinary incontinence in women with type 1 diabetes. Diabetes Care 39, 1587\u20131593 (2016).","journal-title":"Diabetes Care"},{"key":"2175_CR142","first-page":"141","volume":"123","author":"ZA Kamenov","year":"2015","unstructured":"Kamenov, Z. A. A comprehensive review of erectile dysfunction in men with diabetes. Exp. Clin. Endocrinol. Diabetes 123, 141\u2013158 (2015).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2175_CR143","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/life13020502","volume":"13","author":"X P\u00e9rez-Aizpurua","year":"2023","unstructured":"P\u00e9rez-Aizpurua, X. et al. Stem cell therapy for erectile dysfunction: a step towards a future treatment. Life 13, 502 (2023).","journal-title":"Life"},{"key":"2175_CR144","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","volume":"76","author":"L Zilliox","year":"2011","unstructured":"Zilliox, L. et al. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 76, 1099\u20131105 (2011).","journal-title":"Neurology"},{"key":"2175_CR145","doi-asserted-by":"publisher","first-page":"204201882210866","DOI":"10.1177\/20420188221086693","volume":"13","author":"AS Abdalrada","year":"2022","unstructured":"Abdalrada, A. S., Abawajy, J., Al-Quraishi, T. & Islam, S. M. S. Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes. Ther. Adv. Endocrinol. Metab. 13, 20420188221086693 (2022).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"2175_CR146","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4158\/EP.13.5.550","volume":"13","author":"CM Casellini","year":"2007","unstructured":"Casellini, C. M. & Vinik, A. I. Clinical manifestations and current treatment options for diabetic neuropathies. Endocr. Pract. 13, 550\u2013566 (2007).","journal-title":"Endocr. Pract."},{"key":"2175_CR147","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00125-020-05316-z","volume":"64","author":"A Eleftheriadou","year":"2021","unstructured":"Eleftheriadou, A. et al. The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review. Diabetologia 64, 288\u2013303 (2021).","journal-title":"Diabetologia"},{"key":"2175_CR148","first-page":"2502","volume":"53","author":"P Novak","year":"2011","unstructured":"Novak, P. Quantitative autonomic testing. J. Vis. Exp 53, 2502 (2011).","journal-title":"J. Vis. Exp"},{"key":"2175_CR149","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/bmj.39192.488125.BE","volume":"334","author":"G Lauria","year":"2007","unstructured":"Lauria, G. & Lombardi, R. Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ 334, 1159\u20131162 (2007).","journal-title":"BMJ"},{"key":"2175_CR150","doi-asserted-by":"publisher","first-page":"102859","DOI":"10.1016\/j.neucli.2023.102859","volume":"53","author":"JP Lefaucheur","year":"2023","unstructured":"Lefaucheur, J. P. The value of electrochemical skin conductance measurement by Sudoscan\u00ae for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes. Neurophysiol. Clin. 53, 102859 (2023).","journal-title":"Neurophysiol. Clin."},{"key":"2175_CR151","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-444-53491-0.00023-7","volume":"117","author":"PE Cryer","year":"2013","unstructured":"Cryer, P. E. Hypoglycemia-associated autonomic failure in diabetes. Handb. Clin. Neurol. 117, 295\u2013307 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR152","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc12-2480","volume":"36","author":"ER Seaquist","year":"2013","unstructured":"Seaquist, E. R. et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384\u20131395 (2013).","journal-title":"Diabetes Care"},{"key":"2175_CR153","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/dc15-0090","volume":"38","author":"P Choudhary","year":"2015","unstructured":"Choudhary, P. et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care 38, 1016\u20131029 (2015).","journal-title":"Diabetes Care"},{"key":"2175_CR154","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1210\/er.2018-00226","volume":"40","author":"S Stanley","year":"2019","unstructured":"Stanley, S., Moheet, A. & Seaquist, E. R. Central mechanisms of glucose sensing and counterregulation in defense of hypoglycemia. Endocr. Rev. 40, 768\u2013788 (2019).","journal-title":"Endocr. Rev."},{"key":"2175_CR155","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/dia.2019.0011","volume":"21","author":"GP Forlenza","year":"2019","unstructured":"Forlenza, G. P. et al. Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial. Diabetes Technol. Ther. 21, 159\u2013169 (2019).","journal-title":"Diabetes Technol. Ther."},{"key":"2175_CR156","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.2337\/dc14-0030","volume":"37","author":"SA Little","year":"2014","unstructured":"Little, S. A. et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 \u00d7 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 37, 2114\u20132122 (2014).","journal-title":"Diabetes Care"},{"key":"2175_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/1475-925X-9-26","volume":"9","author":"GL Ferrari","year":"2010","unstructured":"Ferrari, G. L. et al. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed. Eng. Online 9, 26 (2010).","journal-title":"Biomed. Eng. Online"},{"key":"2175_CR158","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/dme.12752","volume":"32","author":"AG Lerner","year":"2015","unstructured":"Lerner, A. G. et al. Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry. Diabet. Med. 32, 1470\u20131478 (2015).","journal-title":"Diabet. Med."},{"key":"2175_CR159","first-page":"197","volume":"8","author":"Z Tan","year":"2019","unstructured":"Tan, Z., Scheetz, J. & He, M. G. Artificial intelligence in ophthalmology: accuracy, challenges, and clinical application. Asia Pac. J. Ophthalmol. 8, 197\u2013199 (2019).","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"2175_CR160","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ncl.2007.01.002","volume":"25","author":"Y Harati","year":"2007","unstructured":"Harati, Y. Diabetic neuropathies: unanswered questions. Neurol. Clin. 25, 303\u2013317 (2007).","journal-title":"Neurol. Clin."},{"key":"2175_CR161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jfo.2017.06.010","volume":"41","author":"H Lajmi","year":"2018","unstructured":"Lajmi, H. et al. Oculomotor palsy in diabetics. J. Fr. Ophtalmol. 41, 45\u201349 (2018).","journal-title":"J. Fr. Ophtalmol."},{"key":"2175_CR162","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/bmj.329.7465.553","volume":"329","author":"NJ Holland","year":"2004","unstructured":"Holland, N. J. & Weiner, G. M. Recent developments in Bell\u2019s palsy. BMJ 329, 553\u2013557 (2004).","journal-title":"BMJ"},{"key":"2175_CR163","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00264-016-3186-3","volume":"41","author":"NW Lang","year":"2016","unstructured":"Lang, N. W., Ostermann, R. C., Arthold, C., Joestl, J. & Platzer, P. Retrospective case series with one year follow-up after radial nerve palsy associated with humeral fractures. Int. Orthop. 41, 191\u2013196 (2016).","journal-title":"Int. Orthop."},{"key":"2175_CR164","doi-asserted-by":"publisher","first-page":"232596712211214","DOI":"10.1177\/23259671221121410","volume":"10","author":"K Vasavada","year":"2022","unstructured":"Vasavada, K. et al. Predictors using machine learning of complete peroneal nerve palsy recovery after multiligamentous knee injury: a multicenter retrospective cohort study. Orthop. J. Sports Med. 10, 23259671221121410 (2022).","journal-title":"Orthop. J. Sports Med."},{"key":"2175_CR165","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3390\/jcm11061674","volume":"11","author":"M Zimmerman","year":"2022","unstructured":"Zimmerman, M., Gotts\u00e4ter, A. & Dahlin, L. B. Carpal tunnel syndrome and diabetes-a comprehensive review. J. Clin. Med. 11, 1674 (2022).","journal-title":"J. Clin. Med."},{"key":"2175_CR166","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrneurol.2017.42","volume":"13","author":"MP Collins","year":"2017","unstructured":"Collins, M. P. & Hadden, R. D. The nonsystemic vasculitic neuropathies. Nat. Rev. Neurol. 13, 302\u2013316 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR167","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrneurol.2014.117","volume":"10","author":"N Latov","year":"2014","unstructured":"Latov, N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat. Rev. Neurol. 10, 435\u2013446 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR168","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ncpneuro0504","volume":"3","author":"G Said","year":"2007","unstructured":"Said, G. Diabetic neuropathy\u2013a review. Nat. Clin. Pract. Neurol. 3, 331\u2013340 (2007).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"2175_CR169","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1097\/WNP.0000000000000842","volume":"38","author":"P David","year":"2021","unstructured":"David, P. & Barbara, S. Electromyography and neuromuscular disorders: clinical-electrodiagnostic-ultrasound correlations, fourth edition. J. Clin. Neurophysiol. 38, e19 (2021).","journal-title":"J. Clin. Neurophysiol."},{"key":"2175_CR170","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.mcna.2018.10.006","volume":"103","author":"K Barrell","year":"2019","unstructured":"Barrell, K. & Smith, A. G. Peripheral neuropathy. Med. Clin. North Am. 103, 383\u2013397 (2019).","journal-title":"Med. Clin. North Am."},{"key":"2175_CR171","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","volume":"4","author":"BC Kieseier","year":"2018","unstructured":"Kieseier, B. C., Mathey, E. K., Sommer, C. & Hartung, H. P. Immune-mediated neuropathies. Nat. Rev. Dis. Prim. 4, 31 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2175_CR172","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey, K. G., Burns, T. M., Collins, M. P. & Dyck, P. J. Vasculitic neuropathies. Lancet Neurol. 13, 67\u201382 (2014).","journal-title":"Lancet Neurol."},{"key":"2175_CR173","first-page":"Cd007543","volume":"6","author":"BC Callaghan","year":"2012","unstructured":"Callaghan, B. C., Little, A. A., Feldman, E. L. & Hughes, R. A. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, Cd007543 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR174","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2106\/JBJS.16.00719","volume":"98","author":"B Graham","year":"2016","unstructured":"Graham, B. et al. The American Academy of Orthopaedic Surgeons evidence-based clinical practice guideline on: management of carpal tunnel syndrome. J. Bone Jt. Surg. Am. 98, 1750\u20131754 (2016).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"2175_CR175","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/WCO.0b013e32830b84cb","volume":"21","author":"DW Zochodne","year":"2008","unstructured":"Zochodne, D. W. Diabetic polyneuropathy: an update. Curr. Opin. Neurol. 21, 527\u2013533 (2008).","journal-title":"Curr. Opin. Neurol."},{"key":"2175_CR176","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-0041-1729130","volume":"31","author":"N Nischal","year":"2021","unstructured":"Nischal, N., Gupta, S., Lal, K. & Singh, J. P. Performance evaluation of high-resolution ultrasound versus magnetic resonance imaging in diagnosing peripheral nerve pathologies. Indian J. Radiol. Imaging 31, 43\u201348 (2021).","journal-title":"Indian J. Radiol. Imaging"},{"key":"2175_CR177","doi-asserted-by":"publisher","first-page":"956","DOI":"10.2337\/diacare.28.4.956","volume":"28","author":"AJ Boulton","year":"2005","unstructured":"Boulton, A. J. et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956\u2013962 (2005).","journal-title":"Diabetes Care"},{"key":"2175_CR178","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/brain\/aws244","volume":"135","author":"R Massie","year":"2012","unstructured":"Massie, R. et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 135, 3074\u20133088 (2012).","journal-title":"Brain"},{"key":"2175_CR179","doi-asserted-by":"publisher","first-page":"e1188","DOI":"10.1212\/WNL.0000000000007020","volume":"92","author":"PS Ng","year":"2019","unstructured":"Ng, P. S. et al. Lumbosacral radiculoplexus neuropathy: incidence and the association with diabetes mellitus. Neurology 92, e1188\u2013e1194 (2019).","journal-title":"Neurology"},{"key":"2175_CR180","doi-asserted-by":"publisher","first-page":"e2098","DOI":"10.1212\/WNL.0000000000011799","volume":"96","author":"MV Pinto","year":"2021","unstructured":"Pinto, M. V. et al. Lumbosacral radiculoplexus neuropathy: neurologic outcomes and survival in a population-based study. Neurology 96, e2098\u2013e2108 (2021).","journal-title":"Neurology"},{"key":"2175_CR181","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/B978-0-444-52902-2.00033-3","volume":"115","author":"G Said","year":"2013","unstructured":"Said, G. Diabetic neuropathy. Handb. Clin. Neurol. 115, 579\u2013589 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR182","doi-asserted-by":"publisher","first-page":"94","DOI":"10.33590\/emj\/19-00163","volume":"5","author":"JW Albers","year":"2020","unstructured":"Albers, J. W., Jacobson, R. D. & Smyth, D. L. Diabetic amyotrophy: from the basics to the bedside. EMJ 5, 94\u2013103 (2020).","journal-title":"EMJ"},{"key":"2175_CR183","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/brain\/awn093","volume":"131","author":"G Devigili","year":"2008","unstructured":"Devigili, G. et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131, 1912\u20131925 (2008).","journal-title":"Brain"},{"key":"2175_CR184","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1212\/WNL.55.1.83","volume":"55","author":"P Kelkar","year":"2000","unstructured":"Kelkar, P., Masood, M. & Parry, G. J. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 55, 83\u201388 (2000).","journal-title":"Neurology"},{"key":"2175_CR185","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.4065\/72.12.1123","volume":"72","author":"MK Pascoe","year":"1997","unstructured":"Pascoe, M. K., Low, P. A., Windebank, A. J. & Litchy, W. J. Subacute diabetic proximal neuropathy. Mayo Clin. Proc. 72, 1123\u20131132 (1997).","journal-title":"Mayo Clin. Proc."},{"key":"2175_CR186","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s00415-011-5938-8","volume":"258","author":"DS Younger","year":"2011","unstructured":"Younger, D. S. Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literature. J. Neurol. 258, 1364\u20131367 (2011).","journal-title":"J. Neurol."},{"key":"2175_CR187","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-444-53480-4.00004-7","volume":"126","author":"RS Laughlin","year":"2014","unstructured":"Laughlin, R. S. & Dyck, P. J. Diabetic radiculoplexus neuropathies. Handb. Clin. Neurol. 126, 45\u201352 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR188","unstructured":"Anandhanarayanan, A., Teh, K., Goonoo, M., Tesfaye, S. & Selvarajah, D. Diabetic neuropathies. In Endotext [Internet] (MDText. com, Inc., 2022)."},{"key":"2175_CR189","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4103\/0028-3886.44814","volume":"56","author":"MJ Bhanushali","year":"2008","unstructured":"Bhanushali, M. J. & Muley, S. A. Diabetic and non-diabetic lumbosacral radiculoplexus neuropathy. Neurol. India 56, 420\u2013425 (2008).","journal-title":"Neurol. India"},{"key":"2175_CR190","first-page":"Cd006521","volume":"7","author":"YC Chan","year":"2017","unstructured":"Chan, Y. C., Lo, Y. L. & Chan, E. S. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst. Rev. 7, Cd006521 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","volume":"19","author":"JA Tracy","year":"2008","unstructured":"Tracy, J. A. & Dyck, P. J. The spectrum of diabetic neuropathies. Phys. Med. Rehabil. Clin. N. Am. 19, 1\u201326 (2008).","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"2175_CR192","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/dbi15-0034","volume":"65","author":"JI Malone","year":"2016","unstructured":"Malone, J. I. Diabetic central neuropathy: CNS damage related to hyperglycemia. Diabetes 65, 355\u2013357 (2016).","journal-title":"Diabetes"},{"key":"2175_CR193","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1093\/brain\/123.10.2118","volume":"123","author":"JM Kennedy","year":"2000","unstructured":"Kennedy, J. M. & Zochodne, D. W. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 123, 2118\u20132129 (2000).","journal-title":"Brain"},{"key":"2175_CR194","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/ageing\/afaa236","volume":"50","author":"B Grodzinski","year":"2021","unstructured":"Grodzinski, B. et al. The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic review. Age Ageing 50, 705\u2013715 (2021).","journal-title":"Age Ageing"},{"key":"2175_CR195","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.10080","volume":"25","author":"PJB Dyck","year":"2002","unstructured":"Dyck, P. J. B. & Windebank, A. J. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 25, 477\u2013491 (2002).","journal-title":"Muscle Nerve"},{"key":"2175_CR196","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/DMSO.S292991","volume":"14","author":"HL Huang","year":"2021","unstructured":"Huang, H. L. & Wu, S. Application of high-resolution ultrasound on diagnosing diabetic peripheral neuropathy. Diabetes Metab. Syndr. Obes. 14, 139\u2013152 (2021).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"2175_CR197","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.2337\/dc05-2370","volume":"29","author":"N Hotta","year":"2006","unstructured":"Hotta, N. et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 29, 1538\u20131544 (2006).","journal-title":"Diabetes Care"},{"key":"2175_CR198","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.mayocp.2015.01.019","volume":"90","author":"A Matveyenko","year":"2015","unstructured":"Matveyenko, A. & Vella, A. Regenerative medicine in diabetes. Mayo Clin. Proc. 90, 546\u2013554 (2015).","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl","key":"2175_CR199","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","volume":"142","author":"T Roy","year":"2012","unstructured":"Roy, T. & Lloyd, C. E. Epidemiology of depression and diabetes: a systematic review. J. Affect. Disord. 142(Suppl), S8\u2013S21 (2012).","journal-title":"J. Affect. Disord."},{"key":"2175_CR200","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jagp.2019.01.214","volume":"27","author":"AR Atti","year":"2019","unstructured":"Atti, A. R. et al. Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies. Am. J. Geriatr. Psychiatry 27, 625\u2013637 (2019).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"2175_CR201","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1212\/WNL.0b013e3181f25f06","volume":"75","author":"SG van Elderen","year":"2010","unstructured":"van Elderen, S. G. et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology 75, 997\u20131002 (2010).","journal-title":"Neurology"},{"key":"2175_CR202","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson, J. D. et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial. JAMA 315, 2673\u20132682 (2016).","journal-title":"JAMA"},{"key":"2175_CR203","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels, G. J. & Despa, F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat. Rev. Endocrinol. 14, 591\u2013604 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2175_CR204","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/jdi.12452","volume":"7","author":"M Omi","year":"2016","unstructured":"Omi, M. et al. Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti-inflammation phenotypes and ameliorated diabetic polyneuropathy. J. Diabetes Investig. 7, 485\u2013496 (2016).","journal-title":"J. Diabetes Investig."},{"key":"2175_CR205","doi-asserted-by":"publisher","first-page":"104087","DOI":"10.1016\/j.drudis.2024.104087","volume":"29","author":"ZZ Chong","year":"2024","unstructured":"Chong, Z. Z., Menkes, D. L. & Souayah, N. Targeting neuroinflammation in distal symmetrical polyneuropathy in diabetes. Drug Discov. Today 29, 104087 (2024).","journal-title":"Drug Discov. Today"},{"key":"2175_CR206","doi-asserted-by":"publisher","first-page":"108398","DOI":"10.1016\/j.intimp.2021.108398","volume":"102","author":"SH Aghamiri","year":"2022","unstructured":"Aghamiri, S. H., Komlakh, K. & Ghaffari, M. Toll-like receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy. Int. Immunopharmacol. 102, 108398 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"2175_CR207","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","volume":"10","author":"J Scholz","year":"2007","unstructured":"Scholz, J. & Woolf, C. J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 10, 1361\u20131368 (2007).","journal-title":"Nat. Neurosci."},{"key":"2175_CR208","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen, T. S. & Finnerup, N. B. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 13, 924\u2013935 (2014).","journal-title":"Lancet Neurol."},{"key":"2175_CR209","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.dsx.2014.04.029","volume":"9","author":"M Shakeel","year":"2015","unstructured":"Shakeel, M. Recent advances in understanding the role of oxidative stress in diabetic neuropathy. Diabetes Metab. Syndr. 9, 373\u2013378 (2015).","journal-title":"Diabetes Metab. Syndr."},{"key":"2175_CR210","doi-asserted-by":"publisher","first-page":"175955","DOI":"10.1016\/j.ejphar.2023.175955","volume":"956","author":"WJ Zhang","year":"2023","unstructured":"Zhang, W. J. et al. Potential role of Schwann cells in neuropathic pain. Eur. J. Pharmacol. 956, 175955 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"2175_CR211","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1016","volume":"7","author":"RJ Pickering","year":"2018","unstructured":"Pickering, R. J. et al. Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. Clin. Transl. Immunol. 7, e1016 (2018).","journal-title":"Clin. Transl. Immunol."},{"key":"2175_CR212","doi-asserted-by":"publisher","first-page":"1421191","DOI":"10.3389\/fcell.2024.1421191","volume":"12","author":"Q Wang","year":"2024","unstructured":"Wang, Q., Xie, Y. L., Ma, S. C., Luo, H. L. & Qiu, Y. Role of microglia in diabetic neuropathic pain. Front. Cell Dev. Biol. 12, 1421191 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"2175_CR213","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.2337\/dc13-0746","volume":"36","author":"SK Dunnigan","year":"2013","unstructured":"Dunnigan, S. K. et al. Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care 36, 3684\u20133690 (2013).","journal-title":"Diabetes Care"},{"key":"2175_CR214","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1083\/jcb.201702150","volume":"216","author":"S Pan","year":"2017","unstructured":"Pan, S. & Chan, J. R. Regulation and dysregulation of axon infrastructure by myelinating glia. J. Cell Biol. 216, 3903\u20133916 (2017).","journal-title":"J. Cell Biol."},{"key":"2175_CR215","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2015.01.048","volume":"596","author":"CR Cashman","year":"2015","unstructured":"Cashman, C. R. & H\u00f6ke, A. Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci. Lett. 596, 33\u201350 (2015).","journal-title":"Neurosci. Lett."},{"key":"2175_CR216","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.aat1498","volume":"359","author":"A Riccio","year":"2018","unstructured":"Riccio, A. RNA targeting and translation in axons. Science 359, 1331\u20131332 (2018).","journal-title":"Science"},{"key":"2175_CR217","volume":"26","author":"LX Huang","year":"2024","unstructured":"Huang, L. X. et al. Non-coding RNA in schwann cell and peripheral nerve injury: a review. Adv. Biol. 26, e2400357 (2024).","journal-title":"Adv. Biol."},{"key":"2175_CR218","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1021\/acschemneuro.5b00165","volume":"6","author":"JC Ma","year":"2015","unstructured":"Ma, J. C., Pan, P., Anyika, M., Blagg, B. S. & Dobrowsky, R. T. Modulating molecular chaperones improves mitochondrial bioenergetics and decreases the inflammatory transcriptome in diabetic sensory neurons. ACS Chem. Neurosci. 6, 1637\u20131648 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"2175_CR219","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.phrs.2014.02.004","volume":"81","author":"MD Sanna","year":"2014","unstructured":"Sanna, M. D., Quattrone, A., Ghelardini, C. & Galeotti, N. PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy. Pharmacol. Res. 81, 44\u201353 (2014).","journal-title":"Pharmacol. Res."},{"key":"2175_CR220","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.2337\/db15-0133","volume":"64","author":"J Hur","year":"2015","unstructured":"Hur, J. et al. The metabolic syndrome and microvascular complications in a murine model of type 2 diabetes. Diabetes 64, 3294\u20133304 (2015).","journal-title":"Diabetes"},{"key":"2175_CR221","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1242\/dmm.028225","volume":"10","author":"M Kobayashi","year":"2017","unstructured":"Kobayashi, M. et al. Diabetic polyneuropathy, sensory neurons, nuclear structure and spliceosome alterations: a role for CWC22. Dis. Model. Mech. 10, 215\u2013224 (2017).","journal-title":"Dis. Model. Mech."},{"key":"2175_CR222","doi-asserted-by":"publisher","first-page":"558758","DOI":"10.3389\/fneur.2020.558758","volume":"11","author":"BY Fan","year":"2020","unstructured":"Fan, B. Y., Chopp, M., Zhang, Z. G. & Liu, X. S. Emerging roles of microRNAs as biomarkers and therapeutic targets for diabetic neuropathy. Front. Neurol. 11, 558758 (2020).","journal-title":"Front. Neurol."},{"key":"2175_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1139444","volume":"14","author":"YP Han","year":"2023","unstructured":"Han, Y. P. et al. Autophagy and its therapeutic potential in diabetic nephropathy. Front. Endocrinol. (Lausanne) 14, 1139444 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2175_CR224","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625 (2005).","journal-title":"Diabetes"},{"key":"2175_CR225","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070 (2010).","journal-title":"Circ. Res."},{"key":"2175_CR226","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4103\/1673-5374.177745","volume":"11","author":"QR Li","year":"2016","unstructured":"Li, Q. R. et al. Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway. Neural Regen. Res. 11, 345\u2013351 (2016).","journal-title":"Neural Regen. Res."},{"key":"2175_CR227","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/B978-0-444-52902-2.00034-5","volume":"115","author":"AM Vincent","year":"2013","unstructured":"Vincent, A. M., Calabek, B., Roberts, L. & Feldman, E. L. Biology of diabetic neuropathy. Handb. Clin. Neurol. 115, 591\u2013606 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR228","doi-asserted-by":"publisher","first-page":"5383797","DOI":"10.1155\/2016\/5383797","volume":"2016","author":"J Satoh","year":"2016","unstructured":"Satoh, J., Kohara, N., Sekiguchi, K. & Yamaguchi, Y. Effect of ranirestat on sensory and motor nerve function in japanese patients with diabetic polyneuropathy: a randomized double-blind placebo-controlled study. J. Diabetes Res. 2016, 5383797 (2016).","journal-title":"J. Diabetes Res."},{"key":"2175_CR229","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.2337\/diacare.24.10.1776","volume":"24","author":"N Hotta","year":"2001","unstructured":"Hotta, N. et al. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 24, 1776\u20131782 (2001).","journal-title":"Diabetes Care"},{"key":"2175_CR230","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/dc09-1893","volume":"33","author":"S Abhary","year":"2010","unstructured":"Abhary, S. et al. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care 33, 1834\u20131836 (2010).","journal-title":"Diabetes Care"},{"key":"2175_CR231","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.biotechadv.2020.107512","volume":"40","author":"P Coussement","year":"2020","unstructured":"Coussement, P., Bauwens, D., Peters, G., Maertens, J. & De Mey, M. Mapping and refactoring pathway control through metabolic and protein engineering: the hexosamine biosynthesis pathway. Biotechnol. Adv. 40, 107512 (2020).","journal-title":"Biotechnol. Adv."},{"key":"2175_CR232","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/cells9122635","volume":"9","author":"N Krause","year":"2020","unstructured":"Krause, N. & Wegner, A. Fructose metabolism in cancer. Cells 9, 2635 (2020).","journal-title":"Cells"},{"key":"2175_CR233","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes, H. P. et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9, 294\u2013299 (2003).","journal-title":"Nat. Med."},{"key":"2175_CR234","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2337\/dc11-1895","volume":"35","author":"DA Fraser","year":"2012","unstructured":"Fraser, D. A. et al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 35, 1095\u20131097 (2012).","journal-title":"Diabetes Care"},{"key":"2175_CR235","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.2337\/dc06-0531","volume":"29","author":"A Stirban","year":"2006","unstructured":"Stirban, A. et al. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29, 2064\u20132071 (2006).","journal-title":"Diabetes Care"},{"key":"2175_CR236","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh, R., Barden, A., Mori, T. & Beilin, L. Advanced glycation end-products: a review. Diabetologia 44, 129\u2013146 (2001).","journal-title":"Diabetologia"},{"key":"2175_CR237","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrneph.2010.54","volume":"6","author":"V D\u2019Agati","year":"2010","unstructured":"D\u2019Agati, V. & Schmidt, A. M. RAGE and the pathogenesis of chronic kidney disease. Nat. Rev. Nephrol. 6, 352\u2013360 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"2175_CR238","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin, A., Beckman, J. A., Schmidt, A. M. & Creager, M. A. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114, 597\u2013605 (2006).","journal-title":"Circulation"},{"key":"2175_CR239","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","volume":"419","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley, P. J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419, 31\u201340 (2003).","journal-title":"Arch. Biochem. Biophys."},{"key":"2175_CR240","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","volume":"63","author":"G Basta","year":"2004","unstructured":"Basta, G., Schmidt, A. M. & De Caterina, R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 63, 582\u2013592 (2004).","journal-title":"Cardiovasc. Res."},{"key":"2175_CR241","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5152\/eurasianjmed.2019.18434","volume":"51","author":"C Toprak","year":"2019","unstructured":"Toprak, C. & Yigitaslan, S. Alagebrium and complications of diabetes mellitus. Eurasia. J. Med. 51, 285\u2013292 (2019).","journal-title":"Eurasia. J. Med."},{"key":"2175_CR242","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"JX Zhu","year":"2023","unstructured":"Zhu, J. X. et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front. Endocrinol. (Lausanne) 14, 1265372 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2175_CR243","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1517\/13543784.10.9.1653","volume":"10","author":"J Kamei","year":"2001","unstructured":"Kamei, J., Mizoguchi, H., Narita, M. & Tseng, L. F. Therapeutic potential of PKC inhibitors in painful diabetic neuropathy. Expert Opin. Investig. Drugs 10, 1653\u20131664 (2001).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2175_CR244","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11302-019-09679-w","volume":"15","author":"T Dal-Cim","year":"2019","unstructured":"Dal-Cim, T. et al. Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen\/glucose deprivation in cortical astrocyte cultures: involvement of A1 and A2A adenosine receptors and PI3K, MEK, and PKC pathways. Purinergic Signal 15, 465\u2013476 (2019).","journal-title":"Purinergic Signal"},{"key":"2175_CR245","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1142\/S0192415X17500926","volume":"45","author":"Y Zan","year":"2017","unstructured":"Zan, Y., Kuai, C. X., Qiu, Z. X. & Huang, F. Berberine ameliorates diabetic neuropathy: TRPV1 modulation by PKC pathway. Am. J. Chin. Med. 45, 1709\u20131723 (2017).","journal-title":"Am. J. Chin. Med."},{"key":"2175_CR246","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2337\/db08-1771","volume":"58","author":"TD Wiggin","year":"2009","unstructured":"Wiggin, T. D. et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58, 1634\u20131640 (2009).","journal-title":"Diabetes"},{"key":"2175_CR247","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jns.12111","volume":"20","author":"MS Yorek","year":"2015","unstructured":"Yorek, M. S. et al. Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl\/6J mice. J. Peripher. Nerv. Syst. 20, 24\u201331 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2175_CR248","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/dmrr.1088","volume":"26","author":"EP Davidson","year":"2010","unstructured":"Davidson, E. P., Coppey, L. J., Calcutt, N. A., Oltman, C. L. & Yorek, M. A. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab. Res. Rev. 26, 306\u2013318 (2010).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR249","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1523\/JNEUROSCI.1852-20.2021","volume":"41","author":"M Sajic","year":"2021","unstructured":"Sajic, M. et al. High dietary fat consumption impairs axonal mitochondrial function in vivo. J. Neurosci. 41, 4321\u20134334 (2021).","journal-title":"J. Neurosci."},{"key":"2175_CR250","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1523\/JNEUROSCI.3173-18.2019","volume":"39","author":"AE Rumora","year":"2019","unstructured":"Rumora, A. E. et al. The divergent roles of dietary saturated and monounsaturated fatty acids on nerve function in murine models of obesity. J. Neurosci. 39, 3770\u20133781 (2019).","journal-title":"J. Neurosci."},{"key":"2175_CR251","first-page":"717","volume":"10","author":"LM Hinder","year":"2017","unstructured":"Hinder, L. M. et al. Dietary reversal of neuropathy in a murine model of prediabetes and metabolic syndrome. Dis. Model. Mech. 10, 717\u2013725 (2017).","journal-title":"Dis. Model. Mech."},{"key":"2175_CR252","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2010.11.013","volume":"1370","author":"A Padilla","year":"2011","unstructured":"Padilla, A., Descorbeth, M., Almeyda, A. L., Payne, K. & De Leon, M. Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res 1370, 64\u201379 (2011).","journal-title":"Brain Res"},{"key":"2175_CR253","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.2337\/db09-0047","volume":"58","author":"AM Vincent","year":"2009","unstructured":"Vincent, A. M. et al. Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1. Diabetes 58, 2376\u20132385 (2009).","journal-title":"Diabetes"},{"key":"2175_CR254","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/10623320802125433","volume":"15","author":"T Honjo","year":"2008","unstructured":"Honjo, T. et al. Essential role of NOXA1 in generation of reactive oxygen species induced by oxidized low-density lipoprotein in human vascular endothelial cells. Endothelium 15, 137\u2013141 (2008).","journal-title":"Endothelium"},{"key":"2175_CR255","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jnr.22205","volume":"88","author":"M Nowicki","year":"2010","unstructured":"Nowicki, M. et al. Oxidized low-density lipoprotein (oxLDL)-induced cell death in dorsal root ganglion cell cultures depends not on the lectin-like oxLDL receptor-1 but on the toll-like receptor-4. J. Neurosci. Res. 88, 403\u2013412 (2010).","journal-title":"J. Neurosci. Res."},{"key":"2175_CR256","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/S0024-3205(03)00508-3","volume":"73","author":"MA Cotter","year":"2003","unstructured":"Cotter, M. A. & Cameron, N. E. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 73, 1813\u20131824 (2003).","journal-title":"Life Sci."},{"key":"2175_CR257","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1210\/en.2006-0073","volume":"148","author":"AM Vincent","year":"2007","unstructured":"Vincent, A. M. et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548\u2013558 (2007).","journal-title":"Endocrinology"},{"key":"2175_CR258","doi-asserted-by":"publisher","first-page":"dmm042101","DOI":"10.1242\/dmm.042101","volume":"13","author":"PD O\u2019Brien","year":"2020","unstructured":"O\u2019Brien, P. D. et al. Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Dis. Model. Mech. 13, dmm042101 (2020).","journal-title":"Dis. Model. Mech."},{"key":"2175_CR259","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/brain\/awr228","volume":"134","author":"J Hur","year":"2011","unstructured":"Hur, J. et al. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134, 3222\u20133235 (2011).","journal-title":"Brain"},{"key":"2175_CR260","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2337\/dc20-1004","volume":"43","author":"FP Kristensen","year":"2020","unstructured":"Kristensen, F. P. et al. Statin therapy and risk of polyneuropathy in type 2 diabetes: a Danish cohort study. Diabetes Care 43, 2945\u20132952 (2020).","journal-title":"Diabetes Care"},{"key":"2175_CR261","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/1753-0407.12013","volume":"5","author":"EF Tierney","year":"2013","unstructured":"Tierney, E. F., Thurman, D. J., Beckles, G. L. & Cadwell, B. L. Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older. J. Diabetes 5, 207\u2013215 (2013).","journal-title":"J. Diabetes"},{"key":"2175_CR262","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1093\/cvr\/cvab034","volume":"117","author":"MA Rogers","year":"2021","unstructured":"Rogers, M. A. et al. Dynamin-related protein 1 inhibition reduces hepatic PCSK9 secretion. Cardiovasc. Res. 117, 2340\u20132353 (2021).","journal-title":"Cardiovasc. Res."},{"key":"2175_CR263","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1507\/endocrj.EJ23-0359","volume":"71","author":"N Cui","year":"2024","unstructured":"Cui, N. et al. Protective effect of alirocumab, a PCSK9 inhibitor, on the sciatic nerve of rats with diabetic peripheral neuropathy. Endocr. J. 71, 233\u2013244 (2024).","journal-title":"Endocr. J."},{"key":"2175_CR264","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1007\/s12035-023-03342-7","volume":"60","author":"QX Lin","year":"2023","unstructured":"Lin, Q. X. et al. Oxidative stress in diabetic peripheral neuropathy: pathway and mechanism-based treatment. Mol. Neurobiol. 60, 4574\u20134594 (2023).","journal-title":"Mol. Neurobiol."},{"key":"2175_CR265","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1368-5031.2006.00825.x","volume":"60","author":"E Wright Jr","year":"2006","unstructured":"Wright, E. Jr, Scism-Bacon, J. L. & Glass, L. C. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract. 60, 308\u2013314 (2006).","journal-title":"Int. J. Clin. Pract."},{"key":"2175_CR266","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12325-019-01148-5","volume":"37","author":"M Rekatsina","year":"2020","unstructured":"Rekatsina, M. et al. Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: a narrative review. Adv. Ther. 37, 113\u2013139 (2020).","journal-title":"Adv. Ther."},{"key":"2175_CR267","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/ars.2020.8047","volume":"33","author":"S Urner","year":"2020","unstructured":"Urner, S., Ho, F., Jha, J. C., Ziegler, D. & Jandeleit-Dahm, K. NADPH oxidase inhibition: preclinical and clinical studies in diabetic complications. Antioxid. Redox Signal. 33, 415\u2013434 (2020).","journal-title":"Antioxid. Redox Signal."},{"key":"2175_CR268","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.3","volume":"47","author":"B Kim","year":"2015","unstructured":"Kim, B. & Feldman, E. L. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp. Mol. Med. 47, e149 (2015).","journal-title":"Exp. Mol. Med."},{"key":"2175_CR269","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.7150\/ijbs.75402","volume":"18","author":"C Cai","year":"2022","unstructured":"Cai, C. et al. Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies. Int. J. Biol. Sci. 18, 5276\u20135290 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2175_CR270","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan, Y. et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat. Rev. Cardiol. 17, 585\u2013607 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"2175_CR271","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nbd.2012.03.016","volume":"51","author":"SK Chowdhury","year":"2013","unstructured":"Chowdhury, S. K., Smith, D. R. & Fernyhough, P. The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol. Dis. 51, 56\u201365 (2013).","journal-title":"Neurobiol. Dis."},{"key":"2175_CR272","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mito.2019.06.002","volume":"49","author":"BN Whitley","year":"2019","unstructured":"Whitley, B. N., Engelhart, E. A. & Hoppins, S. Mitochondrial dynamics and their potential as a therapeutic target. Mitochondrion 49, 269\u2013283 (2019).","journal-title":"Mitochondrion"},{"key":"2175_CR273","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5483\/BMBRep.2010.43.8.513","volume":"43","author":"NA Sims","year":"2010","unstructured":"Sims, N. A. & Walsh, N. C. GP130 cytokines and bone remodelling in health and disease. BMB Rep. 43, 513\u2013523 (2010).","journal-title":"BMB Rep."},{"key":"2175_CR274","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01167-9","volume":"19","author":"H Zhu","year":"2020","unstructured":"Zhu, H. et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol. Cancer 19, 49 (2020).","journal-title":"Mol. Cancer"},{"key":"2175_CR275","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s11011-023-01239-x","volume":"38","author":"S Patel","year":"2023","unstructured":"Patel, S., Pangarkar, A., Mahajan, S. & Majumdar, A. Therapeutic potential of endoplasmic reticulum stress inhibitors in the treatment of diabetic peripheral neuropathy. Metab. Brain Dis. 38, 1841\u20131856 (2023).","journal-title":"Metab. Brain Dis."},{"key":"2175_CR276","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cbi.2017.10.031","volume":"278","author":"AD Kandhare","year":"2017","unstructured":"Kandhare, A. D., Mukherjee, A. & Bodhankar, S. L. Antioxidant for treatment of diabetic nephropathy: a systematic review and meta-analysis. Chem. Biol. Interact. 278, 212\u2013221 (2017).","journal-title":"Chem. Biol. Interact."},{"key":"2175_CR277","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/nu15163634","volume":"15","author":"RY Hsieh","year":"2023","unstructured":"Hsieh, R. Y., Huang, I. C., Chen, C. & Sung, J. Y. Effects of oral alpha-lipoic acid treatment on diabetic polyneuropathy: a meta-analysis and systematic review. Nutrients 15, 3634 (2023).","journal-title":"Nutrients"},{"key":"2175_CR278","doi-asserted-by":"publisher","first-page":"8837893","DOI":"10.1155\/2020\/8837893","volume":"2020","author":"Q Jiang","year":"2020","unstructured":"Jiang, Q. et al. Mitochondria-targeted antioxidants: a step towards disease treatment. Oxid. Med. Cell. Longev. 2020, 8837893 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2175_CR279","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/med.21285","volume":"34","author":"M Rocha","year":"2014","unstructured":"Rocha, M. et al. Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes. Med. Res. Rev. 34, 160\u2013189 (2014).","journal-title":"Med. Res. Rev."},{"key":"2175_CR280","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jff.2015.01.005","volume":"18","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar, A., Serban, M. C., Ursoniu, S. & Banach, M. Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J. Funct. Foods 18, 898\u2013909 (2015).","journal-title":"J. Funct. Foods"},{"key":"2175_CR281","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00592-009-0129-0","volume":"46","author":"SF Praet","year":"2009","unstructured":"Praet, S. F. & van Loon, L. J. Exercise therapy in type 2 diabetes. Acta Diabetol. 46, 263\u2013278 (2009).","journal-title":"Acta Diabetol."},{"key":"2175_CR282","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61531-z","volume":"10","author":"H Kahal","year":"2020","unstructured":"Kahal, H. et al. Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects. Sci. Rep. 10, 4750 (2020).","journal-title":"Sci. Rep."},{"key":"2175_CR283","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji, R. R., Chamessian, A. & Zhang, Y. Q. Pain regulation by non-neuronal cells and inflammation. Science 354, 572\u2013577 (2016).","journal-title":"Science"},{"key":"2175_CR284","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fneur.2018.00268","volume":"9","author":"NP Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves, N. P., V\u00e6gter, C. B. & Pallesen, L. T. Peripheral glial cells in the development of diabetic neuropathy. Front. Neurol. 9, 268 (2018).","journal-title":"Front. Neurol."},{"key":"2175_CR285","doi-asserted-by":"publisher","first-page":"e040521193121","DOI":"10.2174\/1573399817666210504101609","volume":"18","author":"M Yorek","year":"2022","unstructured":"Yorek, M. Treatment for diabetic peripheral neuropathy: what have we learned from animal models? Curr. Diabetes Rev. 18, e040521193121 (2022).","journal-title":"Curr. Diabetes Rev."},{"key":"2175_CR286","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ilar\/ilt052","volume":"54","author":"PD O\u2019Brien","year":"2014","unstructured":"O\u2019Brien, P. D., Sakowski, S. A. & Feldman, E. L. Mouse models of diabetic neuropathy. ILAR J. 54, 259\u2013272 (2014).","journal-title":"ILAR J."},{"key":"2175_CR287","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/jc.2008-2385","volume":"94","author":"J Doupis","year":"2009","unstructured":"Doupis, J. et al. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J. Clin. Endocrinol. Metab. 94, 2157\u20132163 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2175_CR288","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4103\/1673-5374.253510","volume":"14","author":"P Liu","year":"2019","unstructured":"Liu, P. et al. Role of macrophages in peripheral nerve injury and repair. Neural Regen. Res. 14, 1335\u20131342 (2019).","journal-title":"Neural Regen. Res."},{"key":"2175_CR289","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.aanat.2011.02.011","volume":"193","author":"P Dubov\u00fd","year":"2011","unstructured":"Dubov\u00fd, P. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann. Anat. 193, 267\u2013275 (2011).","journal-title":"Ann. Anat."},{"key":"2175_CR290","doi-asserted-by":"publisher","first-page":"3425617","DOI":"10.1155\/2016\/3425617","volume":"2016","author":"LM Roman-Pintos","year":"2016","unstructured":"Roman-Pintos, L. M., Villegas-Rivera, G., Rodriguez-Carrizalez, A. D., Miranda-Diaz, A. G. & Cardona-Munoz, E. G. Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. J. Diabetes Res. 2016, 3425617 (2016).","journal-title":"J. Diabetes Res."},{"key":"2175_CR291","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.567959","volume":"11","author":"Q Sun","year":"2020","unstructured":"Sun, Q. et al. Serum adiponectin levels are positively associated with diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. Front. Endocrinol. 11, 567959 (2020).","journal-title":"Front. Endocrinol."},{"key":"2175_CR292","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(17)30084-4","volume":"16","author":"PD O\u2019Brien","year":"2017","unstructured":"O\u2019Brien, P. D., Hinder, L. M., Callaghan, B. C. & Feldman, E. L. Neurological consequences of obesity. Lancet Neurol. 16, 465\u2013477 (2017).","journal-title":"Lancet Neurol."},{"key":"2175_CR293","doi-asserted-by":"publisher","first-page":"18381","DOI":"10.1523\/JNEUROSCI.3386-11.2011","volume":"31","author":"M Belkouch","year":"2011","unstructured":"Belkouch, M. et al. The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a G\u03b2\u03b3-dependent mechanism. J. Neurosci. 31, 18381\u201318390 (2011).","journal-title":"J. Neurosci."},{"key":"2175_CR294","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3889\/oamjms.2019.646","volume":"7","author":"D Ristikj-Stomnaroska","year":"2019","unstructured":"Ristikj-Stomnaroska, D., Risteska-Nejashmikj, V. & Papazova, M. Role of inflammation in the pathogenesis of diabetic peripheral neuropathy. Open Access Maced. J. Med. Sci. 7, 2267\u20132270 (2019).","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"2175_CR295","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.expneurol.2012.04.018","volume":"236","author":"JK Alexander","year":"2012","unstructured":"Alexander, J. K. et al. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp. Neurol. 236, 351\u2013362 (2012).","journal-title":"Exp. Neurol."},{"key":"2175_CR296","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1007\/s00125-008-1136-3","volume":"51","author":"I Vareniuk","year":"2008","unstructured":"Vareniuk, I., Pavlov, I. A. & Obrosova, I. G. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 51, 2126\u20132133 (2008).","journal-title":"Diabetologia"},{"key":"2175_CR297","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","volume":"16","author":"R Pop-Busui","year":"2016","unstructured":"Pop-Busui, R., Ang, L., Holmes, C., Gallagher, K. & Feldman, E. L. Inflammation as a therapeutic target for diabetic neuropathies. Curr. Diab Rep. 16, 29 (2016).","journal-title":"Curr. Diab Rep."},{"key":"2175_CR298","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2337\/dc16-2259","volume":"40","author":"C Herder","year":"2017","unstructured":"Herder, C. et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 study. Diabetes Care 40, 569\u2013576 (2017).","journal-title":"Diabetes Care"},{"key":"2175_CR299","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/dmrr.2239","volume":"28","author":"S Tesfaye","year":"2012","unstructured":"Tesfaye, S. & Selvarajah, D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab. Res. Rev. 28, 8\u201314 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR300","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","volume":"48","author":"RA Malik","year":"2005","unstructured":"Malik, R. A. et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48, 578\u2013585 (2005).","journal-title":"Diabetologia"},{"key":"2175_CR301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.05.005","volume":"120","author":"JL Edwards","year":"2008","unstructured":"Edwards, J. L., Vincent, A. M., Cheng, H. T. & Feldman, E. L. Diabetic neuropathy: mechanisms to management. Pharmacol. Ther. 120, 1\u201334 (2008).","journal-title":"Pharmacol. Ther."},{"key":"2175_CR302","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jns.2003.09.011","volume":"217","author":"RE Hill","year":"2004","unstructured":"Hill, R. E. & Williams, P. E. Perineurial cell basement membrane thickening and myelinated nerve fibre loss in diabetic and nondiabetic peripheral nerve. J. Neurol. Sci. 217, 157\u2013163 (2004).","journal-title":"J. Neurol. Sci."},{"key":"2175_CR303","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.2337\/diabetes.52.10.2615","volume":"52","author":"S Thrainsdottir","year":"2003","unstructured":"Thrainsdottir, S. et al. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 52, 2615\u20132622 (2003).","journal-title":"Diabetes"},{"key":"2175_CR304","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s004010000287","volume":"101","author":"RA Malik","year":"2001","unstructured":"Malik, R. A. et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 101, 367\u2013374 (2001).","journal-title":"Acta Neuropathol."},{"key":"2175_CR305","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1196\/annals.1333.091","volume":"1043","author":"NE Cameron","year":"2005","unstructured":"Cameron, N. E., Gibson, T. M., Nangle, M. R. & Cotter, M. A. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann. N. Y. Acad. Sci. 1043, 784\u2013792 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2175_CR306","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","volume":"55","author":"LJ Coppey","year":"2006","unstructured":"Coppey, L. J. et al. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55, 341\u2013348 (2006).","journal-title":"Diabetes"},{"key":"2175_CR307","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/jfcm.jfcm_79_21","volume":"28","author":"AA Amir","year":"2021","unstructured":"Amir, A. A. et al. Management of neuropathic pain in patients with diabetic peripheral neuropathy and low back pain in Saudi Arabia: evidence and gaps. J. Fam. Community Med. 28, 155\u2013163 (2021).","journal-title":"J. Fam. Community Med."},{"key":"2175_CR308","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1172\/JCI12188","volume":"107","author":"P Schratzberger","year":"2001","unstructured":"Schratzberger, P. et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107, 1083\u20131092 (2001).","journal-title":"J. Clin. Invest."},{"key":"2175_CR309","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2040622314552071","volume":"6","author":"S Javed","year":"2015","unstructured":"Javed, S., Petropoulos, I. N., Alam, U. & Malik, R. A. Treatment of painful diabetic neuropathy. Ther. Adv. Chronic Dis. 6, 15\u201328 (2015).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"2175_CR310","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","volume":"11","author":"CE Tabit","year":"2010","unstructured":"Tabit, C. E., Chung, W. B., Hamburg, N. M. & Vita, J. A. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev. Endocr. Metab. Disord. 11, 61\u201374 (2010).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2175_CR311","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes, P. & King, G. L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319\u20131331 (2010).","journal-title":"Circ. Res."},{"key":"2175_CR312","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1085-9489.2004.09105.x","volume":"9","author":"GM Leinninger","year":"2004","unstructured":"Leinninger, G. M., Vincent, A. M. & Feldman, E. L. The role of growth factors in diabetic peripheral neuropathy. J. Peripher. Nerv. Syst. 9, 26\u201353 (2004).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2175_CR313","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","volume":"58","author":"L \u00d8stergaard","year":"2015","unstructured":"\u00d8stergaard, L. et al. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia 58, 666\u2013677 (2015).","journal-title":"Diabetologia"},{"key":"2175_CR314","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/B:REMD.0000032411.11422.e0","volume":"5","author":"AM Vincent","year":"2004","unstructured":"Vincent, A. M. & Feldman, E. L. New insights into the mechanisms of diabetic neuropathy. Rev. Endocr. Metab. Disord. 5, 227\u2013236 (2004).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2175_CR315","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/JME-19-0067","volume":"63","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. J. Mol. Endocrinol. 63, 227\u2013238 (2019).","journal-title":"J. Mol. Endocrinol."},{"key":"2175_CR316","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108417","volume":"37","author":"S Tesfaye","year":"2023","unstructured":"Tesfaye, S. et al. Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries. J. Diabetes Complicat. 37, 108417 (2023).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR317","doi-asserted-by":"crossref","unstructured":"Calabek, B., Callaghan, B. & Feldman, E. L. Chapter 22-Therapy for diabetic neuropathy: an overview. in Handbook of Clinical Neurology Vol. 126 (eds Zochodne, D. W. & Malik, R. A.), 317\u2013333 (Elsevier, 2014).","DOI":"10.1016\/B978-0-444-53480-4.00022-9"},{"key":"2175_CR318","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mcn.2004.08.009","volume":"28","author":"TJ Huang","year":"2005","unstructured":"Huang, T. J., Verkhratsky, A. & Fernyhough, P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell. Neurosci. 28, 42\u201354 (2005).","journal-title":"Mol. Cell. Neurosci."},{"key":"2175_CR319","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"2175_CR320","doi-asserted-by":"publisher","first-page":"bqaa017","DOI":"10.1210\/endocr\/bqaa017","volume":"161","author":"P Sangwung","year":"2020","unstructured":"Sangwung, P., Petersen, K. F., Shulman, G. I. & Knowles, J. W. Mitochondrial dysfunction, insulin resistance, and potential genetic implications. Endocrinology 161, bqaa017 (2020).","journal-title":"Endocrinology"},{"key":"2175_CR321","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fnins.2016.00581","volume":"10","author":"CW Grote","year":"2016","unstructured":"Grote, C. W. & Wright, D. E. A role for insulin in diabetic neuropathy. Front. Neurosci. 10, 581 (2016).","journal-title":"Front. Neurosci."},{"key":"2175_CR322","doi-asserted-by":"publisher","first-page":"E750","DOI":"10.1152\/ajpendo.00179.2019","volume":"318","author":"H Cheng","year":"2020","unstructured":"Cheng, H. et al. Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes. Am. J. Physiol. Endocrinol. Metab. 318, E750\u2013E764 (2020).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2175_CR323","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1529-8027.2002.02005.x","volume":"7","author":"K Sugimoto","year":"2002","unstructured":"Sugimoto, K., Murakawa, Y. & Sima, A. A. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J. Peripher. Nerv. Syst. 7, 44\u201353 (2002).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2175_CR324","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/jnr.22728","volume":"90","author":"M Nowicki","year":"2012","unstructured":"Nowicki, M., Kosacka, J., Serke, H., Bl\u00fcher, M. & Spanel-Borowski, K. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome. J. Neurosci. Res. 90, 122\u2013131 (2012).","journal-title":"J. Neurosci. Res."},{"key":"2175_CR325","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2337\/diabetes.52.8.2129","volume":"52","author":"TJ Huang","year":"2003","unstructured":"Huang, T. J. et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52, 2129\u20132136 (2003).","journal-title":"Diabetes"},{"key":"2175_CR326","first-page":"241","volume":"7","author":"KA Coughlan","year":"2014","unstructured":"Coughlan, K. A., Valentine, R. J., Ruderman, N. B. & Saha, A. K. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab. Syndr. Obes. 7, 241\u2013253 (2014).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"2175_CR327","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1210\/en.2011-0029","volume":"152","author":"B Kim","year":"2011","unstructured":"Kim, B., McLean, L. L., Philip, S. S. & Feldman, E. L. Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology 152, 3638\u20133647 (2011).","journal-title":"Endocrinology"},{"key":"2175_CR328","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/brain\/aws097","volume":"135","author":"SK Roy Chowdhury","year":"2012","unstructured":"Roy Chowdhury, S. K. et al. Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135, 1751\u20131766 (2012).","journal-title":"Brain"},{"key":"2175_CR329","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.freeradbiomed.2020.12.021","volume":"164","author":"F Akhter","year":"2021","unstructured":"Akhter, F., Chen, D., Akhter, A., Yan, S. F. & Yan, S. S. Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress. Free Radic. Biol. Med. 164, 429\u2013438 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"2175_CR330","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998242299231011181615","volume":"20","author":"N Aziz","year":"2024","unstructured":"Aziz, N. et al. New horizons in diabetic neuropathies: an updated review on their pathology, diagnosis, mechanism, screening techniques, pharmacological, and future approaches. Curr. Diabetes Rev. 20, e201023222416 (2024).","journal-title":"Curr. Diabetes Rev."},{"key":"2175_CR331","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/01.wco.0000178825.56414.52","volume":"18","author":"KA Sullivan","year":"2005","unstructured":"Sullivan, K. A. & Feldman, E. L. New developments in diabetic neuropathy. Curr. Opin. Neurol. 18, 586\u2013590 (2005).","journal-title":"Curr. Opin. Neurol."},{"key":"2175_CR332","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.2337\/diabetes.53.7.1824","volume":"53","author":"V Brussee","year":"2004","unstructured":"Brussee, V., Cunningham, F. A. & Zochodne, D. W. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53, 1824\u20131830 (2004).","journal-title":"Diabetes"},{"key":"2175_CR333","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.injury.2013.04.014","volume":"44","author":"R Mohammadi","year":"2013","unstructured":"Mohammadi, R., Esmaeil-Sani, Z. & Amini, K. Effect of local administration of insulin-like growth factor I combined with inside-out artery graft on peripheral nerve regeneration. Injury 44, 1295\u20131301 (2013).","journal-title":"Injury"},{"key":"2175_CR334","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.nbd.2011.04.012","volume":"43","author":"G Guo","year":"2011","unstructured":"Guo, G., Kan, M., Martinez, J. A. & Zochodne, D. W. Local insulin and the rapid regrowth of diabetic epidermal axons. Neurobiol. Dis. 43, 414\u2013421 (2011).","journal-title":"Neurobiol. Dis."},{"key":"2175_CR335","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0473-5","volume":"14","author":"JW Albers","year":"2014","unstructured":"Albers, J. W. & Pop-Busui, R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr. Neurol. Neurosci. Rep. 14, 473 (2014).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2175_CR336","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1196\/annals.1338.067","volume":"1043","author":"R Wada","year":"2005","unstructured":"Wada, R. & Yagihashi, S. Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann. N. Y. Acad. Sci. 1043, 598\u2013604 (2005).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2175_CR337","doi-asserted-by":"publisher","first-page":"212571","DOI":"10.1155\/2011\/212571","volume":"2011","author":"CW Grote","year":"2011","unstructured":"Grote, C. W., Morris, J. K., Ryals, J. M., Geiger, P. C. & Wright, D. E. Insulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathy. Exp. Diabetes Res. 2011, 212571 (2011).","journal-title":"Exp. Diabetes Res."},{"key":"2175_CR338","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","volume":"381","author":"A Moran","year":"2013","unstructured":"Moran, A. et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381, 1905\u20131915 (2013).","journal-title":"Lancet"},{"key":"2175_CR339","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/1071576031000083161","volume":"37","author":"MA Yorek","year":"2003","unstructured":"Yorek, M. A. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 37, 471\u2013480 (2003).","journal-title":"Free Radic. Res."},{"key":"2175_CR340","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2337\/dc13-2114","volume":"37","author":"CL Martin","year":"2014","unstructured":"Martin, C. L., Albers, J. W., Pop-Busui, R. & Group, D. E. R. Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 37, 31\u201338 (2014).","journal-title":"Diabetes Care"},{"key":"2175_CR341","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3892\/etm.2021.10445","volume":"22","author":"Y Li","year":"2021","unstructured":"Li, Y., Wang, S. Y., Xiao, Y. H., Liu, B. & Pang, J. L. Nerve growth factor enhances the therapeutic effect of mesenchymal stem cells on diabetic periodontitis. Exp. Ther. Med. 22, 1013 (2021).","journal-title":"Exp. Ther. Med."},{"key":"2175_CR342","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1089\/ten.tea.2014.0713","volume":"21","author":"HY Lee","year":"2015","unstructured":"Lee, H. Y. et al. Human adipose stem cells improve mechanical allodynia and enhance functional recovery in a rat model of neuropathic pain. Tissue Eng. Part A 21, 2044\u20132052 (2015).","journal-title":"Tissue Eng. Part A"},{"key":"2175_CR343","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.amjmed.2012.06.022","volume":"126","author":"VA Fonseca","year":"2013","unstructured":"Fonseca, V. A. et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am. J. Med. 126, 141\u2013149 (2013).","journal-title":"Am. J. Med."},{"key":"2175_CR344","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.2337\/db11-1524","volume":"61","author":"H Shevalye","year":"2012","unstructured":"Shevalye, H. et al. Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats. Diabetes 61, 2126\u20132133 (2012).","journal-title":"Diabetes"},{"key":"2175_CR345","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s11095-010-0141-7","volume":"27","author":"H Yang","year":"2010","unstructured":"Yang, H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm. Res. 27, 1759\u20131771 (2010).","journal-title":"Pharm. Res."},{"key":"2175_CR346","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/polym15092196","volume":"15","author":"LY Duan","year":"2023","unstructured":"Duan, L. Y. et al. Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases. Polymers 15, 2196 (2023).","journal-title":"Polymers"},{"key":"2175_CR347","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneurol.2016.201","volume":"13","author":"NP Goncalves","year":"2017","unstructured":"Goncalves, N. P. et al. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat. Rev. Neurol. 13, 135\u2013147 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR348","doi-asserted-by":"publisher","first-page":"117459","DOI":"10.1016\/j.lfs.2020.117459","volume":"248","author":"YP Liu","year":"2020","unstructured":"Liu, Y. P., Shao, S. J. & Guo, H. D. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life Sci. 248, 117459 (2020).","journal-title":"Life Sci."},{"key":"2175_CR349","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03930-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis. 12, 642 (2021).","journal-title":"Cell Death Dis."},{"key":"2175_CR350","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1523\/JNEUROSCI.5520-03.2004","volume":"24","author":"T Ogata","year":"2004","unstructured":"Ogata, T. et al. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J. Neurosci. 24, 6724\u20136732 (2004).","journal-title":"J. Neurosci."},{"key":"2175_CR351","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neuron.2013.01.012","volume":"77","author":"A Viader","year":"2013","unstructured":"Viader, A. et al. Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron 77, 886\u2013898 (2013).","journal-title":"Neuron"},{"key":"2175_CR352","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2337\/db10-1541","volume":"60","author":"M Pande","year":"2011","unstructured":"Pande, M. et al. Transcriptional profiling of diabetic neuropathy in the BKS db\/db mouse: a model of type 2 diabetes. Diabetes 60, 1981\u20131989 (2011).","journal-title":"Diabetes"},{"key":"2175_CR353","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/antiox12010149","volume":"12","author":"SOM Fideles","year":"2023","unstructured":"Fideles, S. O. M. et al. Influence of the neuroprotective properties of quercetin on regeneration and functional recovery of the nervous system. Antioxidants 12, 149 (2023).","journal-title":"Antioxidants"},{"key":"2175_CR354","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032653","volume":"102","author":"JJ Li","year":"2023","unstructured":"Li, J. J., Guan, R. Q. & Pan, L. M. Mechanism of Schwann cells in diabetic peripheral neuropathy: a review. Medicine 102, e32653 (2023).","journal-title":"Medicine"},{"key":"2175_CR355","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/glia.23200","volume":"65","author":"SY Jang","year":"2017","unstructured":"Jang, S. Y. et al. Schwann cell dedifferentiation-associated demyelination leads to exocytotic myelin clearance in inflammatory segmental demyelination. Glia 65, 1848\u20131862 (2017).","journal-title":"Glia"},{"key":"2175_CR356","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41593-020-0689-4","volume":"23","author":"E Babetto","year":"2020","unstructured":"Babetto, E., Wong, K. M. & Beirowski, B. A glycolytic shift in Schwann cells supports injured axons. Nat. Neurosci. 23, 1215\u20131228 (2020).","journal-title":"Nat. Neurosci."},{"key":"2175_CR357","doi-asserted-by":"publisher","first-page":"105751","DOI":"10.1016\/j.nbd.2022.105751","volume":"170","author":"B Beirowski","year":"2022","unstructured":"Beirowski, B. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration. Neurobiol. Dis. 170, 105751 (2022).","journal-title":"Neurobiol. Dis."},{"key":"2175_CR358","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11892-011-0205-z","volume":"11","author":"D Selvarajah","year":"2011","unstructured":"Selvarajah, D., Wilkinson, I. D., Davies, J., Gandhi, R. & Tesfaye, S. Central nervous system involvement in diabetic neuropathy. Curr. Diab Rep. 11, 310\u2013322 (2011).","journal-title":"Curr. Diab Rep."},{"issue":"Suppl 1","key":"2175_CR359","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1097\/j.pain.0000000000000465","volume":"157","author":"S Tesfaye","year":"2016","unstructured":"Tesfaye, S. et al. Diabetic peripheral neuropathy may not be as its name suggests: evidence from magnetic resonance imaging. Pain 157(Suppl 1), S72\u2013S80 (2016).","journal-title":"Pain"},{"key":"2175_CR360","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2337\/dc13-2610","volume":"37","author":"D Selvarajah","year":"2014","unstructured":"Selvarajah, D. et al. Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathy. Diabetes Care 37, 1681\u20131688 (2014).","journal-title":"Diabetes Care"},{"key":"2175_CR361","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.pain.2014.02.008","volume":"155","author":"SM Gustin","year":"2014","unstructured":"Gustin, S. M. et al. Thalamic activity and biochemical changes in individuals with neuropathic pain after spinal cord injury. Pain 155, 1027\u20131036 (2014).","journal-title":"Pain"},{"key":"2175_CR362","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-10-138","volume":"10","author":"F Cauda","year":"2009","unstructured":"Cauda, F. et al. Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain. BMC Neurosci. 10, 138 (2009).","journal-title":"BMC Neurosci."},{"key":"2175_CR363","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/dmrr.359","volume":"19","author":"D Kapur","year":"2003","unstructured":"Kapur, D. Neuropathic pain and diabetes. Diabetes Metab. Res. Rev. 19, S9\u2013S15 (2003).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR364","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jdiacomp.2018.12.016","volume":"33","author":"TM Hansen","year":"2019","unstructured":"Hansen, T. M. et al. Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes. J. Diabetes Complicat. 33, 323\u2013328 (2019).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR365","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00125-008-1139-0","volume":"51","author":"D Selvarajah","year":"2008","unstructured":"Selvarajah, D. et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 51, 2088\u20132092 (2008).","journal-title":"Diabetologia"},{"key":"2175_CR366","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2337\/db18-0509","volume":"68","author":"D Selvarajah","year":"2019","unstructured":"Selvarajah, D. et al. Structural and functional abnormalities of the primary somatosensory cortex in diabetic peripheral neuropathy: a multimodal MRI study. Diabetes 68, 796\u2013806 (2019).","journal-title":"Diabetes"},{"key":"2175_CR367","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal, N. et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 17, 1113\u2013e1188 (2010).","journal-title":"Eur. J. Neurol."},{"key":"2175_CR368","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/auto.7.1.13044","volume":"7","author":"CD Gonzalez","year":"2011","unstructured":"Gonzalez, C. D. et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 7, 2\u201311 (2011).","journal-title":"Autophagy"},{"key":"2175_CR369","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1228045","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. The role of autophagy in the treatment of type II diabetes and its complications: a review. Front. Endocrinol. 14, 1228045 (2023).","journal-title":"Front. Endocrinol."},{"key":"2175_CR370","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11255-022-03325-y","volume":"55","author":"H Tian","year":"2023","unstructured":"Tian, H., Zheng, X. & Wang, H. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK\/Nrf2 pathway. Int. Urol. Nephrol. 55, 423\u2013436 (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"2175_CR371","first-page":"e240137","volume":"68","author":"FM Liu","year":"2023","unstructured":"Liu, F. M., Li, W., Xie, D. Y., Du, X. J. & Chen, X. L. Metformin ameliorates peripheral neuropathy in diabetic rats by downregulating autophagy via the AMPK pathway. Arch. Endocrinol. Metab. 68, e240137 (2023).","journal-title":"Arch. Endocrinol. Metab."},{"key":"2175_CR372","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.500","volume":"7","author":"A Fleming","year":"2011","unstructured":"Fleming, A., Noda, T., Yoshimori, T. & Rubinsztein, D. C. Chemical modulators of autophagy as biological probes and potential therapeutics. Nat. Chem. Biol. 7, 9\u201317 (2011).","journal-title":"Nat. Chem. Biol."},{"key":"2175_CR373","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","volume":"73","author":"B Pasquier","year":"2016","unstructured":"Pasquier, B. Autophagy inhibitors. Cell. Mol. Life Sci. 73, 985\u20131001 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"2175_CR374","doi-asserted-by":"publisher","first-page":"153749","DOI":"10.1016\/j.phymed.2021.153749","volume":"92","author":"YD Yin","year":"2021","unstructured":"Yin, Y. D., Qu, H., Yang, Q. N., Fang, Z. H. & Gao, R. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy. Phytomedicine 92, 153749 (2021).","journal-title":"Phytomedicine"},{"key":"2175_CR375","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13578-018-0219-1","volume":"8","author":"Y Jin","year":"2018","unstructured":"Jin, Y. et al. Transplantation of endothelial progenitor cells attenuated paraquat-induced acute lung injury via miR-141-3p-Notch-Nrf2 axis. Cell Biosci. 8, 21 (2018).","journal-title":"Cell Biosci."},{"key":"2175_CR376","first-page":"455","volume":"7","author":"LJ Martin","year":"2001","unstructured":"Martin, L. J. Neuronal cell death in nervous system development, disease, and injury (Review). Int. J. Mol. Med. 7, 455\u2013478 (2001).","journal-title":"Int. J. Mol. Med."},{"key":"2175_CR377","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00018-010-0285-y","volume":"67","author":"LA Pradelli","year":"2010","unstructured":"Pradelli, L. A., Beneteau, M. & Ricci, J. E. Mitochondrial control of caspase-dependent and-independent cell death. Cell. Mol. Life Sci. 67, 1589\u20131597 (2010).","journal-title":"Cell. Mol. Life Sci."},{"key":"2175_CR378","doi-asserted-by":"publisher","first-page":"e937766","DOI":"10.12659\/MSM.937766","volume":"28","author":"NS Erekat","year":"2022","unstructured":"Erekat, N. S. Programmed cell death in diabetic nephropathy: a review of apoptosis, autophagy, and necroptosis. Med. Sci. Monit. 28, e937766 (2022).","journal-title":"Med. Sci. Monit."},{"key":"2175_CR379","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1159\/000508372","volume":"45","author":"JF Zhan","year":"2020","unstructured":"Zhan, J. F., Huang, H. W., Huang, C., Hu, L. L. & Xu, W. W. Long non-coding RNA NEAT1 regulates pyroptosis in diabetic nephropathy via mediating the miR-34c\/NLRP3 axis. Kidney Blood Press. Res. 45, 589\u2013602 (2020).","journal-title":"Kidney Blood Press. Res."},{"key":"2175_CR380","doi-asserted-by":"publisher","first-page":"480739","DOI":"10.1155\/2013\/480739","volume":"2013","author":"G Ramesh","year":"2013","unstructured":"Ramesh, G., MacLean, A. G. & Philipp, M. T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013, 480739 (2013).","journal-title":"Mediators Inflamm."},{"key":"2175_CR381","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon, D. W. et al. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat. Rev. Neurol. 13, 171\u2013191 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR382","doi-asserted-by":"publisher","first-page":"109806","DOI":"10.1016\/j.diabres.2022.109806","volume":"186","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia. Diabetes Res. Clin. Pract. 186, 109806 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR383","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cca.2022.04.011","volume":"531","author":"ZH Cao","year":"2022","unstructured":"Cao, Z. H. et al. Pyroptosis in diabetes and diabetic nephropathy. Clin. Chim. Acta 531, 188\u2013196 (2022).","journal-title":"Clin. Chim. Acta"},{"key":"2175_CR384","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2012.03.056","volume":"500","author":"PP Kang","year":"2012","unstructured":"Kang, P. P., Tian, C. W. & Jia, C. Q. Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy. Gene 500, 1\u20139 (2012).","journal-title":"Gene"},{"key":"2175_CR385","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.2337\/db08-0504","volume":"57","author":"H Lango","year":"2008","unstructured":"Lango, H. et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57, 3129\u20133135 (2008).","journal-title":"Diabetes"},{"key":"2175_CR386","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.rsci.2015.07.001","volume":"22","author":"YF Zhang","year":"2015","unstructured":"Zhang, Y. F. et al. Genome-wide association studies reveal new genetic targets for five panicle traits of international rice varieties. Rice Sci. 22, 217\u2013226 (2015).","journal-title":"Rice Sci."},{"key":"2175_CR387","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/cvr\/cvr024","volume":"90","author":"MA Reddy","year":"2011","unstructured":"Reddy, M. A. & Natarajan, R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc. Res. 90, 421\u2013429 (2011).","journal-title":"Cardiovasc. Res."},{"key":"2175_CR388","doi-asserted-by":"publisher","first-page":"F14","DOI":"10.1152\/ajprenal.00200.2010","volume":"299","author":"LM Villeneuve","year":"2010","unstructured":"Villeneuve, L. M. & Natarajan, R. The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Ren. Physiol. 299, F14\u2013F25 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2175_CR389","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jdiacomp.2012.05.015","volume":"26","author":"H Rafehi","year":"2012","unstructured":"Rafehi, H., El-Osta, A. & Karagiannis, T. C. Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers. J. Diabetes Complicat. 26, 554\u2013561 (2012).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR390","first-page":"94","volume":"3","author":"A Gouri","year":"2015","unstructured":"Gouri, A., Dekaken, A., Chefrour, M. & Guieu, R. Epigenetics and diabetes: current and perspective. Int. J. Diabetes Vasc. Dis. Res 3, 94\u201398 (2015).","journal-title":"Int. J. Diabetes Vasc. Dis. Res"},{"key":"2175_CR391","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2147\/DMSO.S249232","volume":"13","author":"M Wu","year":"2020","unstructured":"Wu, M., Feng, Y. H. & Shi, X. H. Advances with long non-coding RNAs in diabetic peripheral neuropathy. Diabetes Metab. Syndr. Obes. 13, 1429\u20131434 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"2175_CR392","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1523\/JNEUROSCI.1006-23.2023","volume":"43","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Spinal-specific super enhancer in neuropathic pain. J. Neurosci. 43, 8547\u20138561 (2023).","journal-title":"J. Neurosci."},{"key":"2175_CR393","doi-asserted-by":"publisher","first-page":"135058","DOI":"10.1016\/j.neulet.2020.135058","volume":"731","author":"C Meydan","year":"2020","unstructured":"Meydan, C., \u00dc\u00e7eyler, N. & Soreq, H. Non-coding RNA regulators of diabetic polyneuropathy. Neurosci. Lett. 731, 135058 (2020).","journal-title":"Neurosci. Lett."},{"key":"2175_CR394","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/ijms21114020","volume":"21","author":"T Filardi","year":"2020","unstructured":"Filardi, T. et al. Non-coding RNA: role in gestational diabetes pathophysiology and complications. Int. J. Mol. Sci. 21, 4020 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR395","doi-asserted-by":"publisher","first-page":"903472","DOI":"10.3389\/fnins.2022.903472","volume":"16","author":"XY Gao","year":"2022","unstructured":"Gao, X. Y. et al. LncRNA, an emerging approach for neurological diseases treatment by regulating microglia polarization. Front. Neurosci. 16, 903472 (2022).","journal-title":"Front. Neurosci."},{"key":"2175_CR396","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fbioe.2020.00490","volume":"8","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. The construction and analysis of lncRNA\u2013miRNA\u2013mRNA competing endogenous RNA network of schwann cells in diabetic peripheral neuropathy. Front. Bioeng. Biotechnol. 8, 490 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"2175_CR397","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neulet.2018.06.016","volume":"683","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-kappaB signaling pathways. Neurosci. Lett. 683, 13\u201318 (2018).","journal-title":"Neurosci. Lett."},{"key":"2175_CR398","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/toxsci\/kfv167","volume":"148","author":"R Nassirpour","year":"2015","unstructured":"Nassirpour, R. et al. Identification of promising urinary microrna biomarkers in two rat models of glomerular injury. Toxicol. Sci. 148, 35\u201347 (2015).","journal-title":"Toxicol. Sci."},{"key":"2175_CR399","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.micpath.2018.06.031","volume":"123","author":"PY Jiang","year":"2018","unstructured":"Jiang, P. Y., Zhu, X. J., Zhang, Y. N., Zhou, F. F. & Yang, X. F. Protective effects of apigenin on LPS-induced endometritis via activating Nrf2 signaling pathway. Microb. Pathog. 123, 139\u2013143 (2018).","journal-title":"Microb. Pathog."},{"key":"2175_CR400","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2337\/db19-0432","volume":"69","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Exosomes derived from Schwann cells ameliorate peripheral neuropathy in type 2 diabetic mice. Diabetes 69, 749\u2013759 (2020).","journal-title":"Diabetes"},{"key":"2175_CR401","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105141","volume":"25","author":"YP Liu","year":"2022","unstructured":"Liu, Y. P. et al. Schwann cells-derived exosomal miR-21 participates in high glucose regulation of neurite outgrowth. iScience 25, 105141 (2022).","journal-title":"iScience"},{"key":"2175_CR402","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313\u2013321 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"2175_CR403","doi-asserted-by":"publisher","first-page":"646348","DOI":"10.3389\/fcimb.2021.646348","volume":"11","author":"YH Huang","year":"2021","unstructured":"Huang, Y. H. et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front. Cell. Infect. Microbiol. 11, 646348 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2175_CR404","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.3390\/ijms22179641","volume":"22","author":"A Zaky","year":"2021","unstructured":"Zaky, A., Glastras, S. J., Wong, M. Y. W., Pollock, C. A. & Saad, S. The role of the gut microbiome in diabetes and obesity-related kidney disease. Int. J. Mol. Sci. 22, 9641 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2175_CR405","doi-asserted-by":"publisher","first-page":"101507","DOI":"10.1016\/j.beem.2021.101507","volume":"35","author":"M Snelson","year":"2021","unstructured":"Snelson, M., de Pasquale, C., Ekinci, E. I. & Coughlan, M. T. Gut microbiome, prebiotics, intestinal permeability and diabetes complications. Best. Pract. Res. Clin. Endocrinol. Metab. 35, 101507 (2021).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"2175_CR406","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jnutbio.2015.08.011","volume":"27","author":"C Haro","year":"2016","unstructured":"Haro, C. et al. The gut microbial community in metabolic syndrome patients is modified by diet. J. Nutr. Biochem. 27, 27\u201331 (2016).","journal-title":"J. Nutr. Biochem."},{"key":"2175_CR407","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li, J. et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5, 14 (2017).","journal-title":"Microbiome"},{"key":"2175_CR408","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12020-023-03606-1","volume":"84","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis. Endocrine 84, 48\u201362 (2024).","journal-title":"Endocrine"},{"key":"2175_CR409","doi-asserted-by":"publisher","first-page":"eaan5662","DOI":"10.1126\/scitranslmed.aan5662","volume":"11","author":"S Lahiri","year":"2019","unstructured":"Lahiri, S. et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci. Transl. Med. 11, eaan5662 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2175_CR410","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00213-019-05224-0","volume":"236","author":"J Aresti Sanz","year":"2019","unstructured":"Aresti Sanz, J. & El Aidy, S. Microbiota and gut neuropeptides: a dual action of antimicrobial activity and neuroimmune response. Psychopharmacology 236, 1597\u20131609 (2019).","journal-title":"Psychopharmacology"},{"key":"2175_CR411","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41586-020-2288-7","volume":"582","author":"A Burberry","year":"2020","unstructured":"Burberry, A. et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582, 89\u201394 (2020).","journal-title":"Nature"},{"key":"2175_CR412","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4239\/wjd.v13.i3.150","volume":"13","author":"N Nagase","year":"2022","unstructured":"Nagase, N., Ikeda, Y., Tsuji, A., Kitagishi, Y. & Matsuda, S. Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy. World J. Diabetes 13, 150 (2022).","journal-title":"World J. Diabetes"},{"key":"2175_CR413","doi-asserted-by":"publisher","first-page":"110147","DOI":"10.1016\/j.biopha.2020.110147","volume":"127","author":"J Xie","year":"2020","unstructured":"Xie, J. et al. Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level. Biomed. Pharmacother. 127, 110147 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"2175_CR414","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1021\/acschemneuro.4c00012","volume":"15","author":"M Rani","year":"2024","unstructured":"Rani, M., Akhilesh, Chouhan, D., Uniyal, A. & Tiwari, V. Fecal microbiota transplantation-mediated rebalancing of the gut\u2013brain axis alleviates cisplatin-induced neuropathic pain. ACS Chem. Neurosci. 15, 3655\u20133664 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"2175_CR415","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.3390\/nu12113239","volume":"12","author":"O Ojo","year":"2020","unstructured":"Ojo, O., Feng, Q. Q., Ojo, O. O. & Wang, X. H. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Nutrients 12, 3239 (2020).","journal-title":"Nutrients"},{"key":"2175_CR416","doi-asserted-by":"publisher","DOI":"10.1177\/1744806921996520","volume":"17","author":"F Zhou","year":"2021","unstructured":"Zhou, F. et al. Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol. Pain 17, 1744806921996520 (2021).","journal-title":"Mol. Pain"},{"key":"2175_CR417","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/nu16121938","volume":"16","author":"E M\u0142ynarska","year":"2024","unstructured":"M\u0142ynarska, E. et al. Exploring the significance of gut microbiota in diabetes pathogenesis and management-a narrative review. Nutrients 16, 1938 (2024).","journal-title":"Nutrients"},{"key":"2175_CR418","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/MCO.0b013e32834b8082","volume":"14","author":"K Whelan","year":"2011","unstructured":"Whelan, K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr. Opin. Clin. Nutr. Metab. Care 14, 581\u2013587 (2011).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"2175_CR419","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40122-023-00565-3","volume":"13","author":"A Corriero","year":"2024","unstructured":"Corriero, A. et al. Gut microbiota modulation and its implications on neuropathic pain: a comprehensive literature review. Pain Ther. 13, 33\u201351 (2024).","journal-title":"Pain Ther."},{"key":"2175_CR420","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","volume":"73","author":"CA von Hehn","year":"2012","unstructured":"von Hehn, C. A., Baron, R. & Woolf, C. J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 73, 638\u2013652 (2012).","journal-title":"Neuron"},{"key":"2175_CR421","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca, L. et al. Neuropathic pain. Nat. Rev. Dis. Prim. 3, 17002 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2175_CR422","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11892-019-1150-5","volume":"19","author":"P Shillo","year":"2019","unstructured":"Shillo, P. et al. Painful and painless diabetic neuropathies: what is the difference? Curr. Diab Rep. 19, 32 (2019).","journal-title":"Curr. Diab Rep."},{"key":"2175_CR423","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11892-013-0387-7","volume":"13","author":"V Spallone","year":"2013","unstructured":"Spallone, V. & Greco, C. Painful and painless diabetic neuropathy: one disease or two? Curr. Diab Rep. 13, 533\u2013549 (2013).","journal-title":"Curr. Diab Rep."},{"key":"2175_CR424","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrneurol.2012.97","volume":"8","author":"JG Hoeijmakers","year":"2012","unstructured":"Hoeijmakers, J. G., Faber, C. G., Lauria, G., Merkies, I. S. & Waxman, S. G. Small-fibre neuropathies\u2013advances in diagnosis, pathophysiology and management. Nat. Rev. Neurol. 8, 369\u2013379 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR425","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00125-017-4438-5","volume":"60","author":"GJ Bonhof","year":"2017","unstructured":"Bonhof, G. J. et al. Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy. Diabetologia 60, 2495\u20132503 (2017).","journal-title":"Diabetologia"},{"key":"2175_CR426","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jpain.2013.03.005","volume":"14","author":"HT Cheng","year":"2013","unstructured":"Cheng, H. T. et al. Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy. J. Pain 14, 941\u2013947 (2013).","journal-title":"J. Pain"},{"key":"2175_CR427","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejpain.2010.06.011","volume":"15","author":"V Spallone","year":"2011","unstructured":"Spallone, V. et al. Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur. J. Pain 15, 153\u2013160 (2011).","journal-title":"Eur. J. Pain"},{"key":"2175_CR428","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2015.05.044","volume":"355","author":"S Scheytt","year":"2015","unstructured":"Scheytt, S., Riediger, N., Braunsdorf, S., Sommer, C. & Uceyler, N. Increased gene expression of growth associated protein-43 in skin of patients with early-stage peripheral neuropathies. J. Neurol. Sci. 355, 131\u2013137 (2015).","journal-title":"J. Neurol. Sci."},{"key":"2175_CR429","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/mus.24351","volume":"51","author":"A Cheung","year":"2015","unstructured":"Cheung, A., Podgorny, P., Martinez, J. A., Chan, C. & Toth, C. Epidermal axonal swellings in painful and painless diabetic peripheral neuropathy. Muscle Nerve 51, 505\u2013513 (2015).","journal-title":"Muscle Nerve"},{"key":"2175_CR430","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3361","volume":"37","author":"U Alam","year":"2021","unstructured":"Alam, U. et al. Vitamin D deficiency is associated with painful diabetic neuropathy. Diabetes Metab. Res. Rev. 37, e3361 (2021).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR431","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2337\/dc09-2314","volume":"33","author":"RA Gandhi","year":"2010","unstructured":"Gandhi, R. A., Marques, J. L., Selvarajah, D., Emery, C. J. & Tesfaye, S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care 33, 1585\u20131590 (2010).","journal-title":"Diabetes Care"},{"key":"2175_CR432","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","volume":"229","author":"PJ Austin","year":"2010","unstructured":"Austin, P. J. & Moalem-Taylor, G. The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26\u201350 (2010).","journal-title":"J. Neuroimmunol."},{"key":"2175_CR433","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3892\/mmr.2015.3735","volume":"12","author":"JS Sun","year":"2015","unstructured":"Sun, J. S. et al. Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol. Med. Rep. 12, 2677\u20132682 (2015).","journal-title":"Mol. Med. Rep."},{"key":"2175_CR434","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/nm.2750","volume":"18","author":"A Bierhaus","year":"2012","unstructured":"Bierhaus, A. et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat. Med. 18, 926\u2013933 (2012).","journal-title":"Nat. Med."},{"key":"2175_CR435","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/JPR.S21751","volume":"4","author":"TE Purwata","year":"2011","unstructured":"Purwata, T. E. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J. Pain Res. 4, 169\u2013175 (2011).","journal-title":"J. Pain Res."},{"key":"2175_CR436","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.2337\/diacare.25.10.1699","volume":"25","author":"KC Yuen","year":"2002","unstructured":"Yuen, K. C., Baker, N. R. & Rayman, G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 25, 1699\u20131703 (2002).","journal-title":"Diabetes Care"},{"key":"2175_CR437","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2337\/dc14-1403","volume":"38","author":"C Herder","year":"2015","unstructured":"Herder, C. et al. Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study. Diabetes Care 38, 91\u201396 (2015).","journal-title":"Diabetes Care"},{"key":"2175_CR438","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0009-2","volume":"7","author":"C Herder","year":"2018","unstructured":"Herder, C. et al. Association between pro-and anti-inflammatory cytokines and depressive symptoms in patients with diabetes\u2014potential differences by diabetes type and depression scores. Transl. Psychiatry 7, 1 (2018).","journal-title":"Transl. Psychiatry"},{"key":"2175_CR439","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1292\/jvms.21-0429","volume":"83","author":"Y Matsushita","year":"2021","unstructured":"Matsushita, Y. et al. Inhibition of transient receptor potential vanilloid type 1 through \u03b12 adrenergic receptors at peripheral nerve terminals relieves pain. J. Vet. Med. Sci. 83, 1570\u20131581 (2021).","journal-title":"J. Vet. Med. Sci."},{"key":"2175_CR440","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/WNR.0000000000001138","volume":"29","author":"P Li","year":"2018","unstructured":"Li, P., Xiong, D. L., Sun, W. P. & Xu, S. Y. Effects of baicalin on diabetic neuropathic pain involving transient receptor potential vanilloid 1 in the dorsal root ganglia of rats. Neuroreport 29, 1492\u20131498 (2018).","journal-title":"Neuroreport"},{"key":"2175_CR441","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainres.2017.06.004","volume":"1670","author":"EI Araya","year":"2017","unstructured":"Araya, E. I. et al. Role of peripheral and central TRPV1 receptors in facial heat hyperalgesia in streptozotocin-induced diabetic rats. Brain Res. 1670, 146\u2013155 (2017).","journal-title":"Brain Res."},{"key":"2175_CR442","doi-asserted-by":"publisher","first-page":"e77986","DOI":"10.1371\/journal.pone.0077986","volume":"8","author":"DA Andersson","year":"2013","unstructured":"Andersson, D. A. et al. Methylglyoxal evokes pain by stimulating TRPA1. PLoS ONE 8, e77986 (2013).","journal-title":"PLoS ONE"},{"key":"2175_CR443","doi-asserted-by":"publisher","DOI":"10.1177\/1744806918789812","volume":"14","author":"H Hiyama","year":"2018","unstructured":"Hiyama, H. et al. TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy. Mol. Pain 14, 1744806918789812 (2018).","journal-title":"Mol. Pain"},{"key":"2175_CR444","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.phrs.2011.10.006","volume":"65","author":"A Koivisto","year":"2012","unstructured":"Koivisto, A. et al. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol. Res. 65, 149\u2013158 (2012).","journal-title":"Pharmacol. Res."},{"key":"2175_CR445","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1523\/JNEUROSCI.2203-07.2007","volume":"27","author":"H Xing","year":"2007","unstructured":"Xing, H., Chen, M., Ling, J., Tan, W. H. & Gu, J. G. TRPM8 mechanism of cold allodynia after chronic nerve injury. J. Neurosci. 27, 13680\u201313690 (2007).","journal-title":"J. Neurosci."},{"key":"2175_CR446","first-page":"029","volume":"2017","author":"MR Pabbidi","year":"2017","unstructured":"Pabbidi, M. R. & Premkumar, L. S. Role of transient receptor potential channels TRPV1 and TRPM8 in diabetic peripheral neuropathy. J. Diabetes Treat. 2017, 029 (2017).","journal-title":"J. Diabetes Treat."},{"key":"2175_CR447","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00424-014-1452-z","volume":"466","author":"SM Todorovic","year":"2014","unstructured":"Todorovic, S. M. & Jevtovic-Todorovic, V. Targeting of CaV3.2 t-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy. Pflug. Arch. 466, 701\u2013706 (2014).","journal-title":"Pflug. Arch."},{"key":"2175_CR448","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pain.2009.06.012","volume":"145","author":"RB Messinger","year":"2009","unstructured":"Messinger, R. B. et al. In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145, 184\u2013195 (2009).","journal-title":"Pain"},{"key":"2175_CR449","doi-asserted-by":"publisher","first-page":"e91467","DOI":"10.1371\/journal.pone.0091467","volume":"9","author":"A Obradovic","year":"2014","unstructured":"Obradovic, A. et al. CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy. PLoS ONE 9, e91467 (2014).","journal-title":"PLoS ONE"},{"key":"2175_CR450","doi-asserted-by":"publisher","first-page":"605312","DOI":"10.3389\/fncel.2020.605312","volume":"14","author":"SL Joksimovic","year":"2020","unstructured":"Joksimovic, S. L. et al. Glycosylation of CaV3.2 channels contributes to the hyperalgesia in peripheral neuropathy of type 1 diabetes. Front. Cell. Neurosci. 14, 605312 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"2175_CR451","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pharmthera.2005.06.002","volume":"109","author":"H Franke","year":"2006","unstructured":"Franke, H. & Illes, P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 109, 297\u2013324 (2006).","journal-title":"Pharmacol. Ther."},{"key":"2175_CR452","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuroscience.2018.12.003","volume":"398","author":"JM Teixeira","year":"2019","unstructured":"Teixeira, J. M. et al. Diabetes-induced neuropathic mechanical hyperalgesia depends on P2X4 receptor activation in dorsal root ganglia. Neuroscience 398, 158\u2013170 (2019).","journal-title":"Neuroscience"},{"key":"2175_CR453","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00125-021-05416-4","volume":"64","author":"K Teh","year":"2021","unstructured":"Teh, K. et al. Somatosensory network functional connectivity differentiates clinical pain phenotypes in diabetic neuropathy. Diabetologia 64, 1412\u20131421 (2021).","journal-title":"Diabetologia"},{"key":"2175_CR454","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/brain\/awx337","volume":"141","author":"AR Segerdahl","year":"2018","unstructured":"Segerdahl, A. R., Themistocleous, A. C., Fido, D., Bennett, D. L. & Tracey, I. A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy. Brain 141, 357\u2013364 (2018).","journal-title":"Brain"},{"key":"2175_CR455","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","volume":"19","author":"GJ Biessels","year":"2020","unstructured":"Biessels, G. J., Nobili, F., Teunissen, C. E., Simo, R. & Scheltens, P. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol. 19, 699\u2013710 (2020).","journal-title":"Lancet Neurol."},{"key":"2175_CR456","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15948-9","volume":"11","author":"TJ Littlejohns","year":"2020","unstructured":"Littlejohns, T. J. et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat. Commun. 11, 2624 (2020).","journal-title":"Nat. Commun."},{"key":"2175_CR457","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf, C. J. Central sensitization: iImplications for the diagnosis and treatment of pain. Pain 152, S2\u2013S15 (2011).","journal-title":"Pain"},{"key":"2175_CR458","doi-asserted-by":"publisher","first-page":"10277","DOI":"10.1523\/JNEUROSCI.22-23-10277.2002","volume":"22","author":"NT Blair","year":"2002","unstructured":"Blair, N. T. & Bean, B. P. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277\u201310290 (2002).","journal-title":"J. Neurosci."},{"key":"2175_CR459","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-444-53480-4.00013-8","volume":"126","author":"L Vileikyte","year":"2014","unstructured":"Vileikyte, L. & Gonzalez, J. S. Recognition and management of psychosocial issues in diabetic neuropathy. Handb. Clin. Neurol. 126, 195\u2013209 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR460","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","volume":"55","author":"I Tracey","year":"2007","unstructured":"Tracey, I. & Mantyh, P. W. The cerebral signature for pain perception and its modulation. Neuron 55, 377\u2013391 (2007).","journal-title":"Neuron"},{"key":"2175_CR461","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brainres.2009.02.063","volume":"1268","author":"TZ Fischer","year":"2009","unstructured":"Fischer, T. Z., Tan, A. M. & Waxman, S. G. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 1268, 154\u2013161 (2009).","journal-title":"Brain Res."},{"key":"2175_CR462","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrneurol.2010.90","volume":"6","author":"TZ Fischer","year":"2010","unstructured":"Fischer, T. Z. & Waxman, S. G. Neuropathic pain in diabetes\u2013evidence for a central mechanism. Nat. Rev. Neurol. 6, 462\u2013466 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"2175_CR463","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/jnnp-2017-316601","volume":"89","author":"K Watanabe","year":"2018","unstructured":"Watanabe, K. et al. Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain. J. Neurol. Neurosurg. Psychiatry 89, 1082\u20131087 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2175_CR464","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/hbm.22105","volume":"34","author":"MT Tseng","year":"2013","unstructured":"Tseng, M. T., Chiang, M. C., Chao, C. C., Tseng, W. Y. & Hsieh, S. T. fMRI evidence of degeneration-induced neuropathic pain in diabetes: enhanced limbic and striatal activations. Hum. Brain Mapp. 34, 2733\u20132746 (2013).","journal-title":"Hum. Brain Mapp."},{"key":"2175_CR465","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2337\/db20-0029","volume":"69","author":"ID Wilkinson","year":"2020","unstructured":"Wilkinson, I. D. et al. Determinants of treatment response in painful diabetic peripheral neuropathy: a combined deep sensory phenotyping and multimodal brain MRI study. Diabetes 69, 1804\u20131814 (2020).","journal-title":"Diabetes"},{"key":"2175_CR466","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4239\/wjd.v6.i1.80","volume":"6","author":"AS Balc\u0131o\u011flu","year":"2015","unstructured":"Balc\u0131o\u011flu, A. S. & M\u00fcderriso\u011flu, H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J. Diabetes 6, 80 (2015).","journal-title":"World J. Diabetes"},{"key":"2175_CR467","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0140-6736(05)74815-7","volume":"365","author":"R Freeman","year":"2005","unstructured":"Freeman, R. Autonomic peripheral neuropathy. Lancet 365, 1259\u20131270 (2005).","journal-title":"Lancet"},{"key":"2175_CR468","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373\u2013498 (2021).","journal-title":"Eur. Heart J."},{"key":"2175_CR469","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/1474515114565215","volume":"15","author":"J Ybarra-Mu\u00f1oz","year":"2016","unstructured":"Ybarra-Mu\u00f1oz, J. et al. Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: a 10-year prospective study. Eur. J. Cardiovasc. Nurs. 15, 248\u2013254 (2016).","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"2175_CR470","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ajg.2012.373","volume":"108","author":"M Camilleri","year":"2013","unstructured":"Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L. & Gerson, L. Clinical guideline: management of gastroparesis. Am. J. Gastroenterol. 108, 18\u201337 (2013). quiz 38.","journal-title":"Am. J. Gastroenterol."},{"key":"2175_CR471","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ncpgasthep1054","volume":"5","author":"JH Sellin","year":"2008","unstructured":"Sellin, J. H. & Chang, E. B. Therapy insight: gastrointestinal complications of diabetes\u2014pathophysiology and management. Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 162\u2013171 (2008).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"2175_CR472","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-6156.1000402","volume":"5","author":"N Kaur","year":"2014","unstructured":"Kaur, N., Kishore, L. & Singh, R. Diabetic autonomic neuropathy: pathogenesis to pharmacological management. J. Diabetes Metab. 5, 1\u20138 (2014).","journal-title":"J. Diabetes Metab."},{"key":"2175_CR473","doi-asserted-by":"publisher","first-page":"567","DOI":"10.17219\/acem\/67961","volume":"27","author":"AE Zawada","year":"2018","unstructured":"Zawada, A. E., Moszak, M., Skrzypczak, D. & Grzymis\u0142awski, M. Gastrointestinal complications in patients with diabetes mellitus. Adv. Clin. Exp. Med. 27, 567\u2013572 (2018).","journal-title":"Adv. Clin. Exp. Med."},{"key":"2175_CR474","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s11845-022-03191-8","volume":"192","author":"MSO Ahmed","year":"2023","unstructured":"Ahmed, M. S. O., Forde, H. & Smith, D. Diabetic gastroparesis: clinical features, diagnosis and management. Ir. J. Med. Sci. 192, 1687\u20131694 (2023).","journal-title":"Ir. J. Med. Sci."},{"key":"2175_CR475","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2337\/diacare.28.1.177","volume":"28","author":"JS Brown","year":"2005","unstructured":"Brown, J. S. et al. Urologic complications of diabetes. Diabetes Care 28, 177\u2013185 (2005).","journal-title":"Diabetes Care"},{"key":"2175_CR476","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4158\/EP.9.1.52","volume":"9","author":"N Koppiker","year":"2003","unstructured":"Koppiker, N., Boolell, M. & Price, D. Recent advances in the treatment of erectile dysfunction in patients with diabetes mellitus. Endocr. Pract. 9, 52\u201363 (2003).","journal-title":"Endocr. Pract."},{"key":"2175_CR477","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1523\/JNEUROSCI.0033-21.2021","volume":"41","author":"L Grundy","year":"2021","unstructured":"Grundy, L. et al. Activation of MrgprA3 and MrgprC11 on bladder-innervating afferents induces peripheral and central hypersensitivity to bladder distension. J. Neurosci. 41, 3900\u20133916 (2021).","journal-title":"J. Neurosci."},{"key":"2175_CR478","doi-asserted-by":"publisher","first-page":"152173","DOI":"10.1016\/j.acthis.2024.152173","volume":"126","author":"N Andlib","year":"2024","unstructured":"Andlib, N., Sajad, M. & Thakur, S. C. Association of diabetes mellitus with risk of reproductive impairment in females: a comprehensive review. Acta Histochem. 126, 152173 (2024).","journal-title":"Acta Histochem."},{"key":"2175_CR479","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ucl.2021.06.014","volume":"48","author":"EL Matz","year":"2021","unstructured":"Matz, E. L. & Terlecki, R. P. Stem cell and gene-based therapy for erectile dysfunction: current status and future needs. Urol. Clin. North Am. 48, 611\u2013619 (2021).","journal-title":"Urol. Clin. North Am."},{"key":"2175_CR480","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdiacomp.2010.03.003","volume":"25","author":"VS Thorve","year":"2011","unstructured":"Thorve, V. S. et al. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J. Diabetes Complicat. 25, 129\u2013136 (2011).","journal-title":"J. Diabetes Complicat."},{"key":"2175_CR481","doi-asserted-by":"crossref","unstructured":"Spallone, V. et al. Diabetic neuropathy: Clinical management\u2014genitourinary dysfunction in diabetes. In Diabetic Neuropathy: Advances in Pathophysiology and Clinical Management 491\u2013529 (Springer International Publishing, 2023).","DOI":"10.1007\/978-3-031-15613-7_28"},{"key":"2175_CR482","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/dc21-2225","volume":"45","author":"JIP van Heck","year":"2022","unstructured":"van Heck, J. I. P. et al. The gut microbiome composition is altered in long-standing type 1 diabetes and associates with glycemic control and disease-related complications. Diabetes Care 45, 2084\u20132094 (2022).","journal-title":"Diabetes Care"},{"key":"2175_CR483","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrgastro.2016.4","volume":"13","author":"RE Ley","year":"2016","unstructured":"Ley, R. E. Gut microbiota in 2015: Prevotella in the gut: choose carefully. Nat. Rev. Gastroenterol. Hepatol. 13, 69\u201370 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2175_CR484","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2016.10.058","volume":"69","author":"R Hinkel","year":"2017","unstructured":"Hinkel, R. et al. Diabetes mellitus-induced microvascular destabilization in the myocardium. J. Am. Coll. Cardiol. 69, 131\u2013143 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2175_CR485","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s12035-013-8537-0","volume":"49","author":"JY Zhou","year":"2014","unstructured":"Zhou, J. Y. & Zhou, S. W. Inflammation: therapeutic targets for diabetic neuropathy. Mol. Neurobiol. 49, 536\u2013546 (2014).","journal-title":"Mol. Neurobiol."},{"key":"2175_CR486","first-page":"373","volume":"36","author":"K Pitarokoili","year":"2023","unstructured":"Pitarokoili, K., Gold, R. & Fisse, A. L. Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies. Curr. Opin. Neurol. 36, 373\u2013381 (2023).","journal-title":"Curr. Opin. Neurol."},{"key":"2175_CR487","doi-asserted-by":"publisher","first-page":"e004806","DOI":"10.1136\/bmjopen-2014-004806","volume":"4","author":"P K\u00e4hler","year":"2014","unstructured":"K\u00e4hler, P. et al. Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ Open 4, e004806 (2014).","journal-title":"BMJ Open"},{"key":"2175_CR488","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2337\/dc18-1613","volume":"42","author":"I Bebu","year":"2019","unstructured":"Bebu, I., Braffett, B. H., Orchard, T. J., Lorenzi, G. M. & Lachin, J. M. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT\/EDIC study. Diabetes Care 42, 1284\u20131289 (2019).","journal-title":"Diabetes Care"},{"key":"2175_CR489","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2337\/diacare.29.02.06.dc05-1549","volume":"29","author":"CL Martin","year":"2006","unstructured":"Martin, C. L. et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 29, 340\u2013344 (2006).","journal-title":"Diabetes Care"},{"key":"2175_CR490","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129\u2013139 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2175_CR491","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2337\/dc20-2700","volume":"44","author":"A Mariam","year":"2021","unstructured":"Mariam, A. et al. A type 2 diabetes subtype responsive to ACCORD intensive glycemia treatment. Diabetes Care 44, 1410\u20131418 (2021).","journal-title":"Diabetes Care"},{"key":"2175_CR492","first-page":"e302","volume":"7","author":"MU Nisar","year":"2015","unstructured":"Nisar, M. U. et al. Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control. Cureus 7, e302 (2015).","journal-title":"Cureus"},{"key":"2175_CR493","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.2337\/dc21-S006","volume":"44","author":"American Diabetes Association.","year":"2021","unstructured":"American Diabetes Association. 6. Glycemic targets: Standards of Medical Care in Diabetes-2021. Diabetes Care 44, S73\u2013S84 (2021).","journal-title":"Diabetes Care"},{"key":"2175_CR494","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi, S. E. et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38, 140\u2013149 (2015).","journal-title":"Diabetes Care"},{"key":"2175_CR495","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc16-0081","volume":"39","author":"BC Callaghan","year":"2016","unstructured":"Callaghan, B. C. et al. Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status. Diabetes Care 39, 801\u2013807 (2016).","journal-title":"Diabetes Care"},{"key":"2175_CR496","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dci19-0014","volume":"42","author":"AB Evert","year":"2019","unstructured":"Evert, A. B. et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42, 731 (2019).","journal-title":"Diabetes Care"},{"key":"2175_CR497","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jama.292.12.1440","volume":"292","author":"K Esposito","year":"2004","unstructured":"Esposito, K. et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440\u20131446 (2004).","journal-title":"JAMA"},{"key":"2175_CR498","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2522\/ptj.20140108","volume":"95","author":"PM Kluding","year":"2015","unstructured":"Kluding, P. M. et al. Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial. Phys. Ther. 95, 223\u2013234 (2015).","journal-title":"Phys. Ther."},{"key":"2175_CR499","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00198-020-05592-w","volume":"32","author":"GR Mohammad Rahimi","year":"2021","unstructured":"Mohammad Rahimi, G. R., Niyazi, A. & Alaee, S. The effect of exercise training on osteocalcin, adipocytokines, and insulin resistance: a systematic review and meta-analysis of randomized controlled trials. Osteoporos. Int. 32, 213\u2013224 (2021).","journal-title":"Osteoporos. Int."},{"key":"2175_CR500","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11892-017-0903-2","volume":"17","author":"P Zhu","year":"2017","unstructured":"Zhu, P., Pan, X. F., Sheng, L., Chen, H. & Pan, A. Cigarette smoking, diabetes, and diabetes complications: call for urgent action. Curr. Diab Rep. 17, 78 (2017).","journal-title":"Curr. Diab Rep."},{"key":"2175_CR501","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2337\/dci20-0023","volume":"43","author":"MA Powers","year":"2020","unstructured":"Powers, M. A. et al. Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care 43, 1636\u20131649 (2020).","journal-title":"Diabetes Care"},{"key":"2175_CR502","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.pec.2015.11.003","volume":"99","author":"CA Chrvala","year":"2016","unstructured":"Chrvala, C. A., Sherr, D. & Lipman, R. D. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ. Couns. 99, 926\u2013943 (2016).","journal-title":"Patient Educ. Couns."},{"key":"2175_CR503","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/acm.2020.0068","volume":"26","author":"R Sawangjit","year":"2020","unstructured":"Sawangjit, R., Thongphui, S., Chaichompu, W. & Phumart, P. Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials. J. Altern. Complement. Med. 26, 1117\u20131129 (2020).","journal-title":"J. Altern. Complement. Med."},{"key":"2175_CR504","doi-asserted-by":"publisher","first-page":"e240524230300","DOI":"10.2174\/0115733998290606240521113832","volume":"21","author":"B Bhrigu","year":"2024","unstructured":"Bhrigu, B., Sharma, S., Kumar, N. & Banik, B. K. Assessment for diabetic neuropathy: treatment and neurobiological perspective. Curr. Diabetes Rev. 21, e240524230300 (2024).","journal-title":"Curr. Diabetes Rev."},{"key":"2175_CR505","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.2337\/dc11-0503","volume":"34","author":"D Ziegler","year":"2011","unstructured":"Ziegler, D. et al. Efficacy and safety of antioxidant treatment with \u03b1-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34, 2054\u20132060 (2011).","journal-title":"Diabetes Care"},{"key":"2175_CR506","doi-asserted-by":"publisher","first-page":"456279","DOI":"10.1155\/2012\/456279","volume":"2012","author":"GS Mijnhout","year":"2012","unstructured":"Mijnhout, G. S., Kollen, B. J., Alkhalaf, A., Kleefstra, N. & Bilo, H. J. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int. J. Endocrinol. 2012, 456279 (2012).","journal-title":"Int. J. Endocrinol."},{"key":"2175_CR507","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1530\/EJE-12-0555","volume":"167","author":"TT Han","year":"2012","unstructured":"Han, T. T., Bai, J. F., Liu, W. & Hu, Y. M. A systematic review and meta-analysis of \u03b1-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur. J. Endocrinol. 167, 465\u2013471 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"2175_CR508","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1002\/jcb.27275","volume":"119","author":"Q Zuo","year":"2018","unstructured":"Zuo, Q. et al. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. J. Cell. Biochem. 119, 9573\u20139582 (2018).","journal-title":"J. Cell. Biochem."},{"key":"2175_CR509","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12020-014-0181-6","volume":"46","author":"HL Deng","year":"2014","unstructured":"Deng, H. L. et al. Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy. Endocrine 46, 445\u2013454 (2014).","journal-title":"Endocrine"},{"key":"2175_CR510","doi-asserted-by":"publisher","first-page":"e13020","DOI":"10.1097\/MD.0000000000013020","volume":"97","author":"DQ Jiang","year":"2018","unstructured":"Jiang, D. Q. et al. Prostaglandin E1 plus methylcobalamin combination therapy versus prostaglandin E1 monotherapy for patients with diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Medicine 97, e13020 (2018).","journal-title":"Medicine"},{"key":"2175_CR511","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.2337\/dc12-1310","volume":"36","author":"NC Kwai","year":"2013","unstructured":"Kwai, N. C. et al. Effects of axonal ion channel dysfunction on quality of life in type 2 diabetes. Diabetes Care 36, 1272\u20131277 (2013).","journal-title":"Diabetes Care"},{"key":"2175_CR512","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/diacare.28.1.89","volume":"28","author":"AA Sima","year":"2005","unstructured":"Sima, A. A., Calvani, M., Mehra, M. & Amato, A. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28, 89\u201394 (2005).","journal-title":"Diabetes Care"},{"key":"2175_CR513","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eurger.2017.01.002","volume":"8","author":"N Veronese","year":"2017","unstructured":"Veronese, N. et al. Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis. Eur. Geriatr. Med. 8, 117\u2013122 (2017).","journal-title":"Eur. Geriatr. Med."},{"key":"2175_CR514","doi-asserted-by":"publisher","first-page":"e28896","DOI":"10.1097\/MD.0000000000028896","volume":"101","author":"AX Zhang","year":"2022","unstructured":"Zhang, A. X. et al. Efficacy and safety of Mudan granules for painful diabetic peripheral neuropathy: a protocol for a double-blind randomized controlled trial. Medicine 101, e28896 (2022).","journal-title":"Medicine"},{"key":"2175_CR515","doi-asserted-by":"publisher","first-page":"e23843","DOI":"10.1097\/MD.0000000000023843","volume":"100","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Salvia miltiorrhiza improves type 2 diabetes: a protocol for systematic review and meta-analysis. Medicine 100, e23843 (2021).","journal-title":"Medicine"},{"key":"2175_CR516","first-page":"609","volume":"32","author":"XD Cheng","year":"2017","unstructured":"Cheng, X. D. et al. Compound Danshen dropping pill in treatment of diabetic peripheral neuropathy. Clin. Focus 32, 609 (2017).","journal-title":"Clin. Focus"},{"key":"2175_CR517","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock, J., Tuchman, M., LaMoreaux, L. & Sharma, U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110, 628\u2013638 (2004).","journal-title":"Pain"},{"key":"2175_CR518","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","volume":"25","author":"M Backonja","year":"2003","unstructured":"Backonja, M. & Glanzman, R. L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin. Ther. 25, 81\u2013104 (2003).","journal-title":"Clin. Ther."},{"key":"2175_CR519","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7326\/M14-2157","volume":"161","author":"BC Callaghan","year":"2014","unstructured":"Callaghan, B. C. & Feldman, E. L. Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs. Ann. Intern. Med. 161, 674\u2013675 (2014).","journal-title":"Ann. Intern. Med."},{"key":"2175_CR520","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","volume":"76","author":"V Bril","year":"2011","unstructured":"Bril, V. et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76, 1758\u20131765 (2011).","journal-title":"Neurology"},{"key":"2175_CR521","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein, D. J., Lu, Y. L., Detke, M. J., Lee, T. C. & Iyengar, S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116, 109\u2013118 (2005).","journal-title":"Pain"},{"key":"2175_CR522","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","volume":"98","author":"R Price","year":"2022","unstructured":"Price, R. et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: Report of the AAN guideline subcommittee. Neurology 98, 31\u201343 (2022).","journal-title":"Neurology"},{"key":"2175_CR523","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","volume":"67","author":"JF Wernicke","year":"2006","unstructured":"Wernicke, J. F. et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67, 1411\u20131420 (2006).","journal-title":"Neurology"},{"key":"2175_CR524","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/AJP.0000000000000343","volume":"32","author":"SM Hossain","year":"2016","unstructured":"Hossain, S. M., Hussain, S. M. & Ekram, A. Duloxetine in painful diabetic neuropathy: a systematic review. Clin. J. Pain 32, 1005\u20131010 (2016).","journal-title":"Clin. J. Pain"},{"key":"2175_CR525","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","volume":"110","author":"MC Rowbotham","year":"2004","unstructured":"Rowbotham, M. C., Goli, V., Kunz, N. R. & Lei, D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110, 697\u2013706 (2004).","journal-title":"Pain"},{"key":"2175_CR526","first-page":"Cd011091","volume":"2015","author":"HC Gallagher","year":"2015","unstructured":"Gallagher, H. C., Gallagher, R. M., Butler, M., Buggy, D. J. & Henman, M. C. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst. Rev. 2015, Cd011091 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR527","first-page":"Cd005454","volume":"2007","author":"T Saarto","year":"2007","unstructured":"Saarto, T. & Wiffen, P. J. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev. 2007, Cd005454 (2007).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR528","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.2337\/dc12-0656","volume":"35","author":"J Boyle","year":"2012","unstructured":"Boyle, J. et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care 35, 2451\u20132458 (2012).","journal-title":"Diabetes Care"},{"key":"2175_CR529","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1185\/03007995.2010.537589","volume":"27","author":"S Schwartz","year":"2011","unstructured":"Schwartz, S. et al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Curr. Med. Res. Opin. 27, 151\u2013162 (2011).","journal-title":"Curr. Med. Res. Opin."},{"key":"2175_CR530","first-page":"Cd003726","volume":"6","author":"RM Duehmke","year":"2017","unstructured":"Duehmke, R. M. et al. Tramadol for neuropathic pain in adults. Cochrane Database Syst. Rev. 6, Cd003726 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR531","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell, D., Haegerich, T. M. & Chou, R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. MMWR Recomm. Rep. 65, 1\u201349 (2016).","journal-title":"MMWR Recomm. Rep."},{"key":"2175_CR532","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","volume":"83","author":"GM Franklin","year":"2014","unstructured":"Franklin, G. M. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 83, 1277\u20131284 (2014).","journal-title":"Neurology"},{"key":"2175_CR533","first-page":"21","volume":"16","author":"YPS Balhara","year":"2020","unstructured":"Balhara, Y. P. S., Singh, S. & Kalra, S. Pragmatic opioid use in painful diabetic neuropathy. Eur. Endocrinol. 16, 21\u201324 (2020).","journal-title":"Eur. Endocrinol."},{"key":"2175_CR534","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpain.2016.09.008","volume":"18","author":"DM Simpson","year":"2017","unstructured":"Simpson, D. M. et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study. J. Pain 18, 42\u201353 (2017).","journal-title":"J. Pain"},{"key":"2175_CR535","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/ALN.0000000000002035","volume":"128","author":"W Ten Hoope","year":"2018","unstructured":"Ten Hoope, W. et al. Pharmacodynamics and pharmacokinetics of lidocaine in a rodent model of diabetic neuropathy. Anesthesiology 128, 609\u2013619 (2018).","journal-title":"Anesthesiology"},{"key":"2175_CR536","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40261-023-01318-y","volume":"43","author":"J Medeiros Dantas","year":"2023","unstructured":"Medeiros Dantas, J. et al. Monotherapy versus combination therapy in the treatment of painful diabetic neuropathy: a systematic review and meta-analysis. Clin. Drug Investig. 43, 905\u2013914 (2023).","journal-title":"Clin. Drug Investig."},{"key":"2175_CR537","doi-asserted-by":"publisher","first-page":"1281485","DOI":"10.3389\/fneur.2023.1281485","volume":"14","author":"LL Zhou","year":"2023","unstructured":"Zhou, L. L., Wu, T., Zhong, Z. S., Yi, L. C. & Li, Y. M. Acupuncture for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Front. Neurol. 14, 1281485 (2023).","journal-title":"Front. Neurol."},{"key":"2175_CR538","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017282","volume":"98","author":"YJ Zhang","year":"2019","unstructured":"Zhang, Y. J. & Liu, F. R. Effectiveness of acupuncture for treatment of diabetic peripheral neuropathy: a protocol for systematic review. Medicine 98, e17282 (2019).","journal-title":"Medicine"},{"key":"2175_CR539","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.2337\/dc14-0684","volume":"37","author":"R Slangen","year":"2014","unstructured":"Slangen, R. et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care 37, 3016\u20133024 (2014).","journal-title":"Diabetes Care"},{"key":"2175_CR540","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.pain.2014.08.031","volume":"155","author":"CC de Vos","year":"2014","unstructured":"de Vos, C. C. et al. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain 155, 2426\u20132431 (2014).","journal-title":"Pain"},{"key":"2175_CR541","doi-asserted-by":"publisher","first-page":"102603","DOI":"10.1016\/j.dsx.2022.102603","volume":"16","author":"SP Tatikola","year":"2022","unstructured":"Tatikola, S. P., Natarajan, V., Desai, V. K., Asirvatham, A. R. & Rajsekhar, H. Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: a systematic review and meta-analysis. Diabetes Metab. Syndr. 16, 102603 (2022).","journal-title":"Diabetes Metab. Syndr."},{"key":"2175_CR542","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s11136-013-0602-7","volume":"23","author":"S Dixit","year":"2014","unstructured":"Dixit, S., Maiya, A. & Shastry, B. Effect of aerobic exercise on quality of life in population with diabetic peripheral neuropathy in type 2 diabetes: a single blind, randomized controlled trial. Qual. Life Res. 23, 1629\u20131640 (2014).","journal-title":"Qual. Life Res."},{"key":"2175_CR543","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.2337\/dc21-S011","volume":"44","author":"American Diabetes Association.","year":"2021","unstructured":"American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2021. Diabetes Care 44, S151\u2013S167 (2021).","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"2175_CR544","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/dmrr.2702","volume":"32","author":"SA Bus","year":"2016","unstructured":"Bus, S. A. et al. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab. Res. Rev. 32(Suppl 1), 99\u2013118 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR545","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/dmrr.850","volume":"24","author":"SA Bus","year":"2008","unstructured":"Bus, S. A. et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab. Res. Rev. 24, S162\u2013S180 (2008).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR546","doi-asserted-by":"publisher","DOI":"10.1186\/s13047-020-00383-2","volume":"13","author":"DG Armstrong","year":"2020","unstructured":"Armstrong, D. G. et al. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J. Foot Ankle Res. 13, 16 (2020).","journal-title":"J. Foot Ankle Res."},{"issue":"Suppl 1","key":"2175_CR547","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1002\/dmrr.827","volume":"24","author":"R van Deursen","year":"2008","unstructured":"van Deursen, R. Footwear for the neuropathic patient: offloading and stability. Diabetes Metab. Res. Rev. 24(Suppl 1), S96\u2013S100 (2008).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2175_CR548","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s40279-017-0747-6","volume":"47","author":"A Lacroix","year":"2017","unstructured":"Lacroix, A., Hortob\u00e1gyi, T., Beurskens, R. & Granacher, U. Effects of supervised vs. unsupervised training programs on balance and muscle strength in older adults: a systematic review and meta-analysis. Sports Med 47, 2341\u20132361 (2017).","journal-title":"Sports Med"},{"key":"2175_CR549","doi-asserted-by":"publisher","first-page":"5146378","DOI":"10.1155\/2017\/5146378","volume":"2017","author":"Y Paliwal","year":"2017","unstructured":"Paliwal, Y., Slattum, P. W. & Ratliff, S. M. Chronic health conditions as a risk factor for falls among the community-dwelling US older adults: z zero-inflated regression modeling approach. Biomed. Res. Int. 2017, 5146378 (2017).","journal-title":"Biomed. Res. Int."},{"key":"2175_CR550","doi-asserted-by":"publisher","first-page":"e001150","DOI":"10.1136\/bmjdrc-2019-001150","volume":"8","author":"K Winkley","year":"2020","unstructured":"Winkley, K. et al. Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res. Care 8, e001150 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"2175_CR551","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08964289.2018.1432549","volume":"45","author":"LM Bogusch","year":"2019","unstructured":"Bogusch, L. M. & O\u2019Brien, W. H. The effects of mindfulness-based interventions on diabetes-related distress, quality of life, and metabolic control among persons with diabetes: a meta-analytic review. Behav. Med. 45, 19\u201329 (2019).","journal-title":"Behav. Med."},{"key":"2175_CR552","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1357633X15571997","volume":"21","author":"E Charova","year":"2015","unstructured":"Charova, E., Dorstyn, D., Tully, P. & Mittag, O. Web-based interventions for comorbid depression and chronic illness: a systematic review. J. Telemed. Telecare 21, 189\u2013201 (2015).","journal-title":"J. Telemed. Telecare"},{"key":"2175_CR553","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli, A. et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin. Auton. Res. 28, 355\u2013362 (2018).","journal-title":"Clin. Auton. Res."},{"key":"2175_CR554","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman, R. Clinical practice. Neurogenic orthostatic hypotension. N. Engl. J. Med. 358, 615\u2013624 (2008).","journal-title":"N. Engl. J. Med."},{"key":"2175_CR555","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/01.wnl.0000223828.28215.0b","volume":"67","author":"CH Gibbons","year":"2006","unstructured":"Gibbons, C. H. & Freeman, R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 67, 28\u201332 (2006).","journal-title":"Neurology"},{"key":"2175_CR556","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/ageing\/afs061","volume":"41","author":"IC Logan","year":"2012","unstructured":"Logan, I. C. & Witham, M. D. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing 41, 587\u2013594 (2012).","journal-title":"Age Ageing"},{"key":"2175_CR557","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10286-015-0271-4","volume":"25","author":"J Jordan","year":"2015","unstructured":"Jordan, J., Cyndya, S. B. & Biaggioni, I. Multiple system atrophy: using clinical pharmacology to reveal pathophysiology. Clin. Auton. Res. 25, 53\u201359 (2015).","journal-title":"Clin. Auton. Res."},{"key":"2175_CR558","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/14779072.2015.1057504","volume":"13","author":"H Kaufmann","year":"2015","unstructured":"Kaufmann, H., Norcliffe-Kaufmann, L. & Palma, J. A. Droxidopa in neurogenic orthostatic hypotension. Expert Rev. Cardiovasc. Ther. 13, 875\u2013891 (2015).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"2175_CR559","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/dc12-0329","volume":"35","author":"AG Liu","year":"2012","unstructured":"Liu, A. G. et al. Reducing the glycemic index or carbohydrate content of mixed meals reduces postprandial glycemia and insulinemia over the entire day but does not affect satiety. Diabetes Care 35, 1633\u20131637 (2012).","journal-title":"Diabetes Care"},{"key":"2175_CR560","first-page":"Cd012868","volume":"5","author":"S Veazie","year":"2021","unstructured":"Veazie, S. et al. Fludrocortisone for orthostatic hypotension. Cochrane Database Syst. Rev. 5, Cd012868 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR561","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann, H. et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83, 328\u2013335 (2014).","journal-title":"Neurology"},{"key":"2175_CR562","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.wnp.0000229946.01494.4c","volume":"23","author":"W Singer","year":"2006","unstructured":"Singer, W., Opfer-Gehrking, T. L., Nickander, K. K., Hines, S. M. & Low, P. A. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J. Clin. Neurophysiol. 23, 476\u2013481 (2006).","journal-title":"J. Clin. Neurophysiol."},{"key":"2175_CR563","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/HYPERTENSIONAHA.118.10844","volume":"71","author":"EN Bardsley","year":"2018","unstructured":"Bardsley, E. N., Davis, H., Buckler, K. J. & Paterson, D. J. Neurotransmitter switching coupled to \u03b2-adrenergic signaling in sympathetic neurons in prehypertensive states. Hypertension 71, 1226\u20131238 (2018).","journal-title":"Hypertension"},{"key":"2175_CR564","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/jnnp-2016-315106.138","volume":"87","author":"P van Vliet","year":"2016","unstructured":"van Vliet, P., Hilt, A. D., Thijs, R. D. & van Dijk, J. G. Effect of orthostatic hypotension on sustained attention in patients with autonomic failure. J. Neurol. Neurosurg. Psychiatry 87, 144\u2013148 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2175_CR565","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jacc.2018.05.079","volume":"72","author":"R Freeman","year":"2018","unstructured":"Freeman, R. et al. Orthostatic Hypotension: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72, 1294\u20131309 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2175_CR566","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1509723","volume":"382","author":"H Kaufmann","year":"2020","unstructured":"Kaufmann, H., Norcliffe-Kaufmann, L. & Palma, J. A. Baroreflex dysfunction. N. Engl. J. Med. 382, 163\u2013178 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2175_CR567","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","volume":"4","author":"M Camilleri","year":"2018","unstructured":"Camilleri, M. et al. Gastroparesis. Nat. Rev. Dis. Prim. 4, 41 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2175_CR568","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","volume":"150","author":"V Stanghellini","year":"2016","unstructured":"Stanghellini, V. et al. Gastroduodenal disorders. Gastroenterology 150, 1380\u20131392 (2016).","journal-title":"Gastroenterology"},{"key":"2175_CR569","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2982.2006.00760.x","volume":"18","author":"TL Abell","year":"2006","unstructured":"Abell, T. L. et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol. Motil. 18, 263\u2013283 (2006).","journal-title":"Neurogastroenterol. Motil."},{"key":"2175_CR570","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncpgasthep0442","volume":"3","author":"PJ Pasricha","year":"2006","unstructured":"Pasricha, P. J., Pehlivanov, N., Sugumar, A. & Jankovic, J. Drug Insight: from disturbed motility to disordered movement\u2013a review of the clinical benefits and medicolegal risks of metoclopramide. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 138\u2013148 (2006).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"2175_CR571","first-page":"375","volume":"15","author":"A Mullard","year":"2016","unstructured":"Mullard, A. FDA approves first drug for Parkinson disease psychosis. Nat. Rev. Drug Discov. 15, 375 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2175_CR572","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0148607103027004277","volume":"27","author":"T Abell","year":"2003","unstructured":"Abell, T. et al. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long\u2010term follow\u2010up. J. Parenter. Enter. Nutr. 27, 277\u2013281 (2003).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"2175_CR573","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cgh.2015.11.021","volume":"14","author":"M Halland","year":"2016","unstructured":"Halland, M. & Bharucha, A. E. Relationship between control of glycemia and gastric emptying disturbances in diabetes mellitus. Clin. Gastroenterol. Hepatol. 14, 929\u2013936 (2016).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2175_CR574","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.ijir.3901494","volume":"19","author":"B Musicki","year":"2007","unstructured":"Musicki, B. & Burnett, A. L. Endothelial dysfunction in diabetic erectile dysfunction. Int. J. Impot. Res. 19, 129\u2013138 (2007).","journal-title":"Int. J. Impot. Res."},{"key":"2175_CR575","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ijir.2010.4","volume":"22","author":"J Yuan","year":"2010","unstructured":"Yuan, J. et al. Vacuum therapy in erectile dysfunction\u2013science and clinical evidence. Int. J. Impot. Res. 22, 211\u2013219 (2010).","journal-title":"Int. J. Impot. Res."},{"key":"2175_CR576","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S0022-5347(05)00309-5","volume":"175","author":"AL Burnett","year":"2006","unstructured":"Burnett, A. L. Erectile dysfunction. J. Urol. 175, S25\u2013S31 (2006).","journal-title":"J. Urol."},{"key":"2175_CR577","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","volume":"62","author":"K Hatzimouratidis","year":"2012","unstructured":"Hatzimouratidis, K. et al. EAU guidelines on penile curvature. Eur. Urol. 62, 543\u2013552 (2012).","journal-title":"Eur. Urol."},{"key":"2175_CR578","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/0269215509353252","volume":"24","author":"JN Panicker","year":"2010","unstructured":"Panicker, J. N., de S\u00e8ze, M. & Fowler, C. J. Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin. Rehabil. 24, 579\u2013589 (2010).","journal-title":"Clin. Rehabil."},{"key":"2175_CR579","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4236\/oju.2024.145031","volume":"14","author":"SV Kamble","year":"2024","unstructured":"Kamble, S. V., Yadav, A. K., Sharma, M. T. & Bhosle, R. R. Bethanechol remains the preferred drug in suspected underactive bladder: findings from nation-wide prescription analysis. Open J. Urol. 14, 301\u2013311 (2024).","journal-title":"Open J. Urol."},{"key":"2175_CR580","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","volume":"43","author":"KE Andersson","year":"2003","unstructured":"Andersson, K. E. & Yoshida, M. Antimuscarinics and the overactive detrusor\u2013which is the main mechanism of action? Eur. Urol. 43, 1\u20135 (2003).","journal-title":"Eur. Urol."},{"key":"2175_CR581","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.eururo.2012.10.048","volume":"63","author":"CR Chapple","year":"2013","unstructured":"Chapple, C. R. et al. Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a \u03b2(3)-adrenoceptor agonist, in overactive bladder. Eur. Urol. 63, 296\u2013305 (2013).","journal-title":"Eur. Urol."},{"key":"2175_CR582","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty, G. et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur. Urol. 53, 275\u2013287 (2008).","journal-title":"Eur. Urol."},{"key":"2175_CR583","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-444-53480-4.00017-5","volume":"126","author":"T V\u00e1rkonyi","year":"2014","unstructured":"V\u00e1rkonyi, T. & Kempler, P. Sexual dysfunction in diabetes. Handb. Clin. Neurol. 126, 223\u2013232 (2014).","journal-title":"Handb. Clin. Neurol."},{"key":"2175_CR584","first-page":"95","volume":"7","author":"MI Maiorino","year":"2014","unstructured":"Maiorino, M. I., Bellastella, G. & Esposito, K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab. Syndr. Obes. 7, 95\u2013105 (2014).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"2175_CR585","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/GME.0b013e318287342d","volume":"20","author":"JA Simon","year":"2013","unstructured":"Simon, J. A., Kokot-Kierepa, M., Goldstein, J. & Nappi, R. E. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause 20, 1043\u20131048 (2013).","journal-title":"Menopause"},{"key":"2175_CR586","first-page":"Cd001843","volume":"1","author":"CA Anderson","year":"2015","unstructured":"Anderson, C. A. et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst. Rev. 1, Cd001843 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR587","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3349\/ymj.2003.44.4.579","volume":"44","author":"WO Kim","year":"2003","unstructured":"Kim, W. O., Kil, H. K., Yoon, D. M. & Cho, M. J. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate. Yonsei Med. J. 44, 579\u2013582 (2003).","journal-title":"Yonsei Med. J."},{"key":"2175_CR588","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1212\/01.WNL.0000036911.75478.FA","volume":"59","author":"DA Restivo","year":"2002","unstructured":"Restivo, D. A. et al. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology 59, 1971\u20131973 (2002).","journal-title":"Neurology"},{"key":"2175_CR589","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"PZ Zhang","year":"2017","unstructured":"Zhang, P. Z. et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann. Med. 49, 106\u2013116 (2017).","journal-title":"Ann. Med."},{"key":"2175_CR590","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.23986","volume":"74","author":"B Callaghan","year":"2013","unstructured":"Callaghan, B. & Feldman, E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann. Neurol. 74, 397\u2013403 (2013).","journal-title":"Ann. Neurol."},{"key":"2175_CR591","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","volume":"17","author":"S van Dieren","year":"2010","unstructured":"van Dieren, S., Beulens, J. W., van der Schouw, Y. T., Grobbee, D. E. & Neal, B. The global burden of diabetes and its complications: an emerging pandemic. Eur. J. Cardiovasc. Prev. Rehabil. 17, S3\u2013S8 (2010).","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"2175_CR592","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14283\/jfa.2017.39","volume":"7","author":"AJ Sinclair","year":"2018","unstructured":"Sinclair, A. J. et al. An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017. J. Frailty Aging 7, 10\u201320 (2018).","journal-title":"J. Frailty Aging"},{"key":"2175_CR593","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/TCRM.S1458","volume":"4","author":"J Jin","year":"2008","unstructured":"Jin, J., Sklar, G. E., Min Sen Oh, V. & Chuen Li, S. Factors affecting therapeutic compliance: a review from the patient\u2019s perspective. Ther. Clin. Risk Manag. 4, 269\u2013286 (2008).","journal-title":"Ther. Clin. Risk Manag."},{"key":"2175_CR594","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.pain.2013.05.043","volume":"154","author":"S Tesfaye","year":"2013","unstructured":"Tesfaye, S. et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The \u201cCOMBO-DN study\u201d\u2013a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 154, 2616\u20132625 (2013).","journal-title":"Pain"},{"key":"2175_CR595","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","volume":"400","author":"S Tesfaye","year":"2022","unstructured":"Tesfaye, S. et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 400, 680\u2013690 (2022).","journal-title":"Lancet"},{"key":"2175_CR596","doi-asserted-by":"publisher","first-page":"e112394","DOI":"10.1371\/journal.pone.0112394","volume":"9","author":"M Oelze","year":"2014","unstructured":"Oelze, M. et al. The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity. PLoS ONE 9, e112394 (2014).","journal-title":"PLoS ONE"},{"key":"2175_CR597","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4093\/dmj.2017.0095","volume":"42","author":"KA Lee","year":"2018","unstructured":"Lee, K. A., Jin, H. Y., Lee, N. Y., Kim, Y. J. & Park, T. S. Effect of empagliflozin, a selective sodium-glucose cotransporter 2 inhibitor, on kidney and peripheral nerves in streptozotocin-induced diabetic rats. Diabetes Metab. J. 42, 338\u2013342 (2018).","journal-title":"Diabetes Metab. J."},{"key":"2175_CR598","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.medcli.2024.01.027","volume":"163","author":"SM El-Haggar","year":"2024","unstructured":"El-Haggar, S. M., Hafez, Y. M., El Sharkawy, A. M. & Khalifa, M. Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus. Med. Clin. 163, 53\u201361 (2024).","journal-title":"Med. Clin."},{"key":"2175_CR599","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/nyas.12852","volume":"1358","author":"N Rosenthal","year":"2015","unstructured":"Rosenthal, N. et al. Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 1358, 28\u201343 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2175_CR600","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2016.11.028","volume":"794","author":"F Naznin","year":"2017","unstructured":"Naznin, F. et al. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice. Eur. J. Pharmacol. 794, 37\u201344 (2017).","journal-title":"Eur. J. Pharmacol."},{"key":"2175_CR601","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.diabet.2022.101331","volume":"48","author":"JL Liao","year":"2022","unstructured":"Liao, J. L. et al. The impact of canagliflozin on the risk of neuropathy events: a post-hoc exploratory analysis of the CREDENCE trial. Diabetes Metab. 48, 101331 (2022).","journal-title":"Diabetes Metab."},{"key":"2175_CR602","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1111\/bcp.14063","volume":"85","author":"C Brock","year":"2019","unstructured":"Brock, C. et al. Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy. Br. J. Clin. Pharmacol. 85, 2512\u20132523 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2175_CR603","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2337\/db10-1462","volume":"60","author":"T Himeno","year":"2011","unstructured":"Himeno, T. et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes 60, 2397\u20132406 (2011).","journal-title":"Diabetes"},{"key":"2175_CR604","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jdiacomp.2015.07.013","volume":"29","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal, M. et al. Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J. Diabetes Complications 29, 1287\u20131294 (2015).","journal-title":"J. Diabetes Complications"},{"key":"2175_CR605","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1111\/dom.15258","volume":"25","author":"T Kimura","year":"2023","unstructured":"Kimura, T. et al. Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: randomized, parallel-group, multicentre, open-label trial (COMING study). Diabetes Obes. Metab. 25, 3632\u20133647 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"2175_CR606","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/dc08-2110","volume":"32","author":"V Bril","year":"2009","unstructured":"Bril, V., Hirose, T., Tomioka, S. & Buchanan, R. Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care 32, 1256\u20131260 (2009).","journal-title":"Diabetes Care"},{"key":"2175_CR607","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-2008-1065351","volume":"116","author":"H Stracke","year":"2008","unstructured":"Stracke, H., Gaus, W., Achenbach, U., Federlin, K. & Bretzel, R. G. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp. Clin. Endocrinol. Diabetes 116, 600\u2013605 (2008).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2175_CR608","doi-asserted-by":"publisher","first-page":"e057142","DOI":"10.1136\/bmjopen-2021-057142","volume":"12","author":"GJ B\u00f6nhof","year":"2022","unstructured":"B\u00f6nhof, G. J. et al. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy. BMJ Open 12, e057142 (2022).","journal-title":"BMJ Open"},{"key":"2175_CR609","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2337\/dc06-1699","volume":"30","author":"CM Casellini","year":"2007","unstructured":"Casellini, C. M. et al. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 30, 896\u2013902 (2007).","journal-title":"Diabetes Care"},{"key":"2175_CR610","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0031-1291248","volume":"120","author":"A Dieckmann","year":"2012","unstructured":"Dieckmann, A., Kriebel, M., Andriambeloson, E., Ziegler, D. & Elmlinger, M. Treatment with Actovegin\u00ae improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. Exp. Clin. Endocrinol. Diabetes 120, 132\u2013138 (2012).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"2175_CR611","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2337\/dc09-0545","volume":"32","author":"D Ziegler","year":"2009","unstructured":"Ziegler, D. et al. Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients. Diabetes Care 32, 1479\u20131484 (2009).","journal-title":"Diabetes Care"},{"key":"2175_CR612","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/pm\/pnab032","volume":"22","author":"HJ Hijma","year":"2021","unstructured":"Hijma, H. J., Siebenga, P. S., de Kam, M. L. & Groeneveld, G. J. A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults. Pain Med. 22, 1814\u20131826 (2021).","journal-title":"Pain Med."},{"key":"2175_CR613","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(17)30005-4","volume":"16","author":"JM Zakrzewska","year":"2017","unstructured":"Zakrzewska, J. M. et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol. 16, 291\u2013300 (2017).","journal-title":"Lancet Neurol."},{"key":"2175_CR614","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101971","volume":"59","author":"CG Faber","year":"2023","unstructured":"Faber, C. G. et al. Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study. EClinicalMedicine 59, 101971 (2023).","journal-title":"EClinicalMedicine"},{"key":"2175_CR615","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.2337\/dc14-1044","volume":"37","author":"A Vinik","year":"2014","unstructured":"Vinik, A. et al. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Diabetes Care 37, 3253\u20133261 (2014).","journal-title":"Diabetes Care"},{"key":"2175_CR616","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jdi.13013","volume":"10","author":"M Baba","year":"2019","unstructured":"Baba, M., Matsui, N., Kuroha, M., Wasaki, Y. & Ohwada, S. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase III study in Asian patients. J. Diabetes Investig. 10, 1299\u20131306 (2019).","journal-title":"J. Diabetes Investig."},{"key":"2175_CR617","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","volume":"156","author":"D Ziegler","year":"2015","unstructured":"Ziegler, D., Duan, W. R., An, G. H., Thomas, J. W. & Nothaft, W. A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain. Pain 156, 2013\u20132020 (2015).","journal-title":"Pain"},{"key":"2175_CR618","doi-asserted-by":"publisher","first-page":"e2425614","DOI":"10.1001\/jamanetworkopen.2024.25614","volume":"7","author":"XH Guo","year":"2024","unstructured":"Guo, X. H. et al. GABA analogue HSK16149 in Chinese patients with diabetic peripheral neuropathic pain: a phase 3 randomized clinical trial. JAMA Netw. Open 7, e2425614 (2024).","journal-title":"JAMA Netw. Open"},{"key":"2175_CR619","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99177-0","volume":"11","author":"AJ Davenport","year":"2021","unstructured":"Davenport, A. J. et al. Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers. Sci. Rep. 11, 19877 (2021).","journal-title":"Sci. Rep."},{"key":"2175_CR620","first-page":"785","volume":"165","author":"D Bouhassira","year":"2024","unstructured":"Bouhassira, D. et al. Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study. Pain 165, 785\u2013795 (2024).","journal-title":"Pain"},{"key":"2175_CR621","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuropharm.2015.05.040","volume":"97","author":"SB Kharatmal","year":"2015","unstructured":"Kharatmal, S. B., Singh, J. N. & Sharma, S. S. Calpain inhibitor, MDL 28170 confer electrophysiological, nociceptive and biochemical improvement in diabetic neuropathy. Neuropharmacology 97, 113\u2013121 (2015).","journal-title":"Neuropharmacology"},{"key":"2175_CR622","doi-asserted-by":"publisher","first-page":"e738","DOI":"10.1097\/j.pain.0000000000002470","volume":"163","author":"SM Jain","year":"2022","unstructured":"Jain, S. M. et al. Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: Impact of preserved small nerve fiber function. Pain 163, e738\u2013e747 (2022).","journal-title":"Pain"},{"key":"2175_CR623","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","volume":"96","author":"CN Sang","year":"2002","unstructured":"Sang, C. N., Booher, S., Gilron, I., Parada, S. & Max, M. B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 96, 1053\u20131061 (2002).","journal-title":"Anesthesiology"},{"key":"2175_CR624","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/cts.12584","volume":"12","author":"DR Houck","year":"2019","unstructured":"Houck, D. R. et al. NYX-2925, A novel N-methyl-D-aspartate receptor modulator: a first-in-human, randomized, double-blind study of safety and pharmacokinetics in adults. Clin. Transl. Sci. 12, 164\u2013171 (2019).","journal-title":"Clin. Transl. Sci."},{"key":"2175_CR625","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/glia.20591","volume":"56","author":"M Tsuda","year":"2008","unstructured":"Tsuda, M. et al. Lyn tyrosine kinase is required for P2X4 receptor upregulation and neuropathic pain after peripheral nerve injury. Glia 56, 50\u201358 (2008).","journal-title":"Glia"},{"key":"2175_CR626","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ejp.1989","volume":"26","author":"E Tiecke","year":"2022","unstructured":"Tiecke, E. et al. NRD.E1, an innovative non-opioid therapy for painful diabetic peripheral neuropathy-a randomized proof of concept study. Eur. J. Pain 26, 1665\u20131678 (2022).","journal-title":"Eur. J. Pain"},{"key":"2175_CR627","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1097\/j.pain.0000000000002252","volume":"162","author":"ASC Rice","year":"2021","unstructured":"Rice, A. S. C. et al. Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy. Pain 162, 2578\u20132589 (2021).","journal-title":"Pain"},{"key":"2175_CR628","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2119\/molmed.2014.00215","volume":"20","author":"M Brines","year":"2015","unstructured":"Brines, M. et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol. Med. 20, 658\u2013666 (2015).","journal-title":"Mol. Med."},{"key":"2175_CR629","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2337\/dc16-0123","volume":"39","author":"RW Simpson","year":"2016","unstructured":"Simpson, R. W. & Wlodarczyk, J. H. Transdermal buprenorphine relieves neuropathic pain: a randomized, double-blind, parallel-group, placebo-controlled trial in diabetic peripheral neuropathic pain. Diabetes Care 39, 1493\u20131500 (2016).","journal-title":"Diabetes Care"},{"key":"2175_CR630","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/pmt.15.68","volume":"6","author":"S Tesfaye","year":"2016","unstructured":"Tesfaye, S. PL37: A new hope in the treatment of painful diabetic neuropathy? Pain Manag. 6, 129\u2013132 (2016).","journal-title":"Pain Manag."},{"key":"2175_CR631","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2008.10.004","volume":"600","author":"K Thibault","year":"2008","unstructured":"Thibault, K. et al. Antinociceptive and anti-allodynic effects of oral PL37, a complete inhibitor of enkephalin-catabolizing enzymes, in a rat model of peripheral neuropathic pain induced by vincristine. Eur. J. Pharmacol. 600, 71\u201377 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"2175_CR632","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1755-5922.2008.00054.x","volume":"26","author":"S Gupta","year":"2008","unstructured":"Gupta, S. & Wright, H. M. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Cardiovasc. Ther. 26, 189\u2013202 (2008).","journal-title":"Cardiovasc. Ther."},{"key":"2175_CR633","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00210-017-1450-8","volume":"391","author":"N Bhadri","year":"2018","unstructured":"Bhadri, N., Razdan, R. & Goswami, S. K. Nebivolol, a \u03b2-blocker abrogates streptozotocin-induced behavioral, biochemical, and neurophysiological deficit by attenuating oxidative-nitrosative stress: a possible target for the prevention of diabetic neuropathy. Naunyn. Schmiedebergs Arch. Pharmacol. 391, 207\u2013217 (2018).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"2175_CR634","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.pain.2012.04.014","volume":"153","author":"CM Campbell","year":"2012","unstructured":"Campbell, C. M. et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 153, 1815\u20131823 (2012).","journal-title":"Pain"},{"key":"2175_CR635","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1124\/jpet.116.235333","volume":"358","author":"W Kostich","year":"2016","unstructured":"Kostich, W. et al. Inhibition of aak1 kinase as a novel therapeutic approach to treat neuropathic pain. J. Pharmacol. Exp. Ther. 358, 371\u2013386 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2175_CR636","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2337\/dc24-0188","volume":"47","author":"R Pop-Busui","year":"2024","unstructured":"Pop-Busui, R. et al. Efficacy and safety of LX9211 for relief of diabetic peripheral neuropathic pain (RELIEF-DPN 1): results of a double-blind, randomized, placebo-controlled, proof-of-concept study. Diabetes Care 47, 1325\u20131332 (2024).","journal-title":"Diabetes Care"},{"key":"2175_CR637","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/acsptsci.4c00186","volume":"7","author":"YY Peng","year":"2024","unstructured":"Peng, Y. Y., Zhang, A. H., Wei, L. P. & Welsh, W. J. Preclinical evaluation of sigma 1 receptor antagonists as a novel treatment for painful diabetic neuropathy. ACS Pharmacol. Transl. Sci. 7, 2358\u20132368 (2024).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"2175_CR638","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ejp.897","volume":"21","author":"N Paniagua","year":"2017","unstructured":"Paniagua, N. et al. Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats. Eur. J. Pain 21, 61\u201372 (2017).","journal-title":"Eur. J. Pain"},{"key":"2175_CR639","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1212\/WNL.0000000000000686","volume":"83","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Fulranumab for treatment of diabetic peripheral neuropathic pain: a randomized controlled trial. Neurology 83, 628\u2013637 (2014).","journal-title":"Neurology"},{"key":"2175_CR640","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/pme.12677","volume":"16","author":"C Bramson","year":"2015","unstructured":"Bramson, C. et al. Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain. Pain Med. 16, 1163\u20131176 (2015).","journal-title":"Pain Med."},{"key":"2175_CR641","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10787-023-01242-9","volume":"31","author":"I Hasan","year":"2023","unstructured":"Hasan, I., Rainsford, K. D. & Ross, J. S. Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases. Inflammopharmacology 31, 2781\u20132797 (2023).","journal-title":"Inflammopharmacology"},{"key":"2175_CR642","first-page":"Cd011265","volume":"6","author":"LC Rolim","year":"2019","unstructured":"Rolim, L. C., da Silva, E. M., Flumignan, R. L., Abreu, M. M. & Dib, S. A. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst. Rev. 6, Cd011265 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2175_CR643","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2337\/db23-0377","volume":"73","author":"LX Guo","year":"2024","unstructured":"Guo, L. X. et al. Acetyllevocarnitine hydrochloride for the treatment of diabetic peripheral neuropathy: a phase 3, randomized clinical trial in China. Diabetes 73, 797\u2013805 (2024).","journal-title":"Diabetes"},{"key":"2175_CR644","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.diabres.2015.01.016","volume":"107","author":"J Wahren","year":"2015","unstructured":"Wahren, J. & Larsson, C. C-peptide: new findings and therapeutic possibilities. Diabetes Res. Clin. Pract. 107, 309\u2013319 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2175_CR645","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/dc15-2068","volume":"39","author":"J Wahren","year":"2016","unstructured":"Wahren, J., Foyt, H., Daniels, M. & Arezzo, J. C. Long-acting C-peptide and neuropathy in type 1 diabetes: a 12-month clinical trial. Diabetes Care 39, 596\u2013602 (2016).","journal-title":"Diabetes Care"},{"key":"2175_CR646","doi-asserted-by":"publisher","first-page":"105274","DOI":"10.1016\/j.phrs.2020.105274","volume":"163","author":"S Pulya","year":"2021","unstructured":"Pulya, S. et al. HDAC6 as privileged target in drug discovery: a perspective. Pharmacol. Res. 163, 105274 (2021).","journal-title":"Pharmacol. Res."},{"key":"2175_CR647","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001114","volume":"8","author":"D Michelson","year":"2023","unstructured":"Michelson, D. et al. A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy. Pain Rep. 8, e1114 (2023).","journal-title":"Pain Rep."},{"key":"2175_CR648","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","volume":"198","author":"L Crigler","year":"2006","unstructured":"Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D. & Phinney, D. G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 198, 54\u201364 (2006).","journal-title":"Exp. Neurol."},{"key":"2175_CR649","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.expneurol.2016.11.006","volume":"288","author":"M Monfrini","year":"2017","unstructured":"Monfrini, M. et al. Therapeutic potential of mesenchymal stem cells for the treatment of diabetic peripheral neuropathy. Exp. Neurol. 288, 75\u201384 (2017).","journal-title":"Exp. Neurol."},{"key":"2175_CR650","doi-asserted-by":"publisher","first-page":"110019","DOI":"10.1016\/j.celrep.2021.110019","volume":"37","author":"M Kawai","year":"2021","unstructured":"Kawai, M. et al. Long-term selective stimulation of transplanted neural stem\/progenitor cells for spinal cord injury improves locomotor function. Cell Rep. 37, 110019 (2021).","journal-title":"Cell Rep."},{"key":"2175_CR651","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/cts.12977","volume":"14","author":"JA Kessler","year":"2021","unstructured":"Kessler, J. A. et al. Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin. Transl. Sci. 14, 1176\u20131184 (2021).","journal-title":"Clin. Transl. Sci."},{"key":"2175_CR652","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/mt.2013.69","volume":"21","author":"S Ajroud-Driss","year":"2013","unstructured":"Ajroud-Driss, S., Christiansen, M., Allen, J. A. & Kessler, J. A. Phase 1\/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy. Mol. Ther. 21, 1279\u20131286 (2013).","journal-title":"Mol. Ther."},{"key":"2175_CR653","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archneur.58.5.761","volume":"58","author":"D Simovic","year":"2001","unstructured":"Simovic, D., Isner, J. M., Ropper, A. H., Pieczek, A. & Weinberg, D. H. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch. Neurol. 58, 761\u2013768 (2001).","journal-title":"Arch. Neurol."},{"key":"2175_CR654","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.cmet.2023.06.010","volume":"35","author":"JP Yang","year":"2023","unstructured":"Yang, J. P. et al. Gut microbiota modulate distal symmetric polyneuropathy in patients with diabetes. Cell Metab. 35, 1548\u20131562.e1547 (2023).","journal-title":"Cell Metab."},{"key":"2175_CR655","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.phrs.2019.02.016","volume":"142","author":"HJ Zheng","year":"2019","unstructured":"Zheng, H. J. et al. The effect of probiotic and synbiotic supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 142, 303\u2013313 (2019).","journal-title":"Pharmacol. Res."},{"key":"2175_CR656","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1212\/WNL.0000000000004033","volume":"88","author":"EJH Lewis","year":"2017","unstructured":"Lewis, E. J. H. et al. Effect of omega-3 supplementation on neuropathy in type 1 diabetes: a 12-month pilot trial. Neurology 88, 2294\u20132301 (2017).","journal-title":"Neurology"},{"key":"2175_CR657","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"LP Zhao","year":"2018","unstructured":"Zhao, L. P. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151\u20131156 (2018).","journal-title":"Science"},{"key":"2175_CR658","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.expneurol.2018.05.011","volume":"306","author":"MA Cooper","year":"2018","unstructured":"Cooper, M. A. et al. A ketogenic diet reduces metabolic syndrome-induced allodynia and promotes peripheral nerve growth in mice. Exp. Neurol. 306, 149\u2013157 (2018).","journal-title":"Exp. Neurol."},{"key":"2175_CR659","doi-asserted-by":"publisher","unstructured":"Karwasra, R., Sharma, S., Sharma, I., Shahid, N. & Umar, T. Diabetology and nanotechnology: a compelling combination. Recent Pat. Nanotechnol. https:\/\/doi.org\/10.2174\/0118722105253055231016155618 (2023).","DOI":"10.2174\/0118722105253055231016155618"},{"key":"2175_CR660","doi-asserted-by":"publisher","first-page":"790747","DOI":"10.3389\/fendo.2021.790747","volume":"12","author":"R Bhandari","year":"2021","unstructured":"Bhandari, R., Sharma, A. & Kuhad, A. Novel nanotechnological approaches for targeting dorsal root ganglion (DRG) in mitigating diabetic neuropathic pain (DNP). Front. Endocrinol. (Lausanne) 12, 790747 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"2175_CR661","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121536","volume":"285","author":"R Latorre","year":"2022","unstructured":"Latorre, R. et al. Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain. Biomaterials 285, 121536 (2022).","journal-title":"Biomaterials"},{"key":"2175_CR662","doi-asserted-by":"publisher","DOI":"10.1186\/1755-7682-5-2","volume":"5","author":"F Imtiaz","year":"2012","unstructured":"Imtiaz, F. et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int. Arch. Med. 5, 2 (2012).","journal-title":"Int. Arch. Med."},{"key":"2175_CR663","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/DDDT.S157109","volume":"12","author":"YH Feng","year":"2018","unstructured":"Feng, Y. H. et al. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des. Dev. Ther. 12, 171\u2013177 (2018).","journal-title":"Drug Des. Dev. Ther."},{"key":"2175_CR664","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12035-015-9632-1","volume":"54","author":"HY Peng","year":"2017","unstructured":"Peng, H. Y. et al. lncRNA NONRATT021972 siRNA decreases diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia. Mol. Neurobiol. 54, 511\u2013523 (2017).","journal-title":"Mol. Neurobiol."},{"key":"2175_CR665","doi-asserted-by":"publisher","first-page":"2941297","DOI":"10.1155\/2017\/2941297","volume":"2017","author":"W Yu","year":"2017","unstructured":"Yu, W., Zhao, G. Q., Cao, R. J., Zhu, Z. H. & Li, K. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes. Behav. Neurol. 2017, 2941297 (2017).","journal-title":"Behav. Neurol."},{"key":"2175_CR666","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2337\/dc13-0590","volume":"36","author":"JB Li","year":"2013","unstructured":"Li, J. B. et al. NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabetes Care 36, 3405\u20133410 (2013).","journal-title":"Diabetes Care"},{"key":"2175_CR667","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13300-019-00716-w","volume":"11","author":"YP Li","year":"2020","unstructured":"Li, Y. P. et al. The Association between phosphorylated neurofilament heavy chain (pNF-H) and small fiber neuropathy (SFN) in patients with impaired glucose tolerance. Diabetes Ther. 11, 71\u201381 (2020).","journal-title":"Diabetes Ther."},{"key":"2175_CR668","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.3390\/cancers12071951","volume":"12","author":"D Bugada","year":"2020","unstructured":"Bugada, D., Lorini, L. F., Fumagalli, R. & Allegri, M. Genetics and opioids: towards more appropriate prescription in cancer pain. Cancers 12, 1951 (2020).","journal-title":"Cancers"},{"key":"2175_CR669","doi-asserted-by":"publisher","first-page":"105083","DOI":"10.1016\/j.phrs.2020.105083","volume":"160","author":"OY Kim","year":"2020","unstructured":"Kim, O. Y. & Song, J. The importance of BDNF and RAGE in diabetes-induced dementia. Pharmacol. Res. 160, 105083 (2020).","journal-title":"Pharmacol. Res."},{"key":"2175_CR670","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.tem.2019.07.012","volume":"30","author":"A Farhadi","year":"2019","unstructured":"Farhadi, A., Vosough, M., Zhang, J. S., Tahamtani, Y. & Shahpasand, K. A possible neurodegeneration mechanism triggered by diabetes. Trends Endocrinol. Metab. 30, 692\u2013700 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"2175_CR671","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","volume":"422","author":"YY Zhao","year":"2013","unstructured":"Zhao, Y. Y. Metabolomics in chronic kidney disease. Clin. Chim. Acta 422, 59\u201369 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"2175_CR672","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49986-4","volume":"15","author":"M Slobodyanyuk","year":"2024","unstructured":"Slobodyanyuk, M. et al. Directional integration and pathway enrichment analysis for multi-omics data. Nat. Commun. 15, 5690 (2024).","journal-title":"Nat. Commun."},{"key":"2175_CR673","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/bib\/bbz103","volume":"21","author":"FE Agamah","year":"2020","unstructured":"Agamah, F. E. et al. Computational\/in silico methods in drug target and lead prediction. Brief. Bioinform. 21, 1663\u20131675 (2020).","journal-title":"Brief. Bioinform."},{"key":"2175_CR674","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306424","volume":"19","author":"GJ Guo","year":"2024","unstructured":"Guo, G. J., Chen, J., Shen, Q. X. & Chen, Z. B. Single-cell transcriptome analysis reveals distinct cell populations in dorsal root ganglia and their potential roles in diabetic peripheral neuropathy. PLoS One 19, e0306424 (2024).","journal-title":"PLoS One"},{"key":"2175_CR675","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s11011-024-01376-x","volume":"39","author":"ZY Yu","year":"2024","unstructured":"Yu, Z. Y. et al. Metabolomic and lipidomic profiling of the spinal cord in type 2 diabetes mellitus rats with painful neuropathy. Metab. Brain Dis. 39, 1117\u20131130 (2024).","journal-title":"Metab. Brain Dis."},{"key":"2175_CR676","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41592-023-01911-1","volume":"20","author":"YH Fan","year":"2023","unstructured":"Fan, Y. H. et al. Expansion spatial transcriptomics. Nat. Methods 20, 1179\u20131182 (2023).","journal-title":"Nat. Methods"},{"key":"2175_CR677","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1380929","volume":"15","author":"A Atmaca","year":"2024","unstructured":"Atmaca, A. et al. Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach. Front. Endocrinol. 15, 1380929 (2024).","journal-title":"Front. Endocrinol."},{"key":"2175_CR678","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2337\/dc08-9021","volume":"31","author":"LA Lavery","year":"2008","unstructured":"Lavery, L. A. et al. Comprehensive foot examination and risk assessment. Diabetes Care 31, 1679 (2008).","journal-title":"Diabetes Care"},{"key":"2175_CR679","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.arr.2011.11.002","volume":"11","author":"NM de Vries","year":"2012","unstructured":"de Vries, N. M. et al. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and\/or multi-morbidity: a meta-analysis. Ageing Res. Rev. 11, 136\u2013149 (2012).","journal-title":"Ageing Res. Rev."},{"key":"2175_CR680","doi-asserted-by":"publisher","first-page":"113078","DOI":"10.1016\/j.bios.2021.113078","volume":"179","author":"Y Yao","year":"2021","unstructured":"Yao, Y. et al. Integration of interstitial fluid extraction and glucose detection in one device for wearable non-invasive blood glucose sensors. Biosens. Bioelectron. 179, 113078 (2021).","journal-title":"Biosens. Bioelectron."},{"key":"2175_CR681","doi-asserted-by":"publisher","first-page":"105355","DOI":"10.1016\/j.compbiomed.2022.105355","volume":"144","author":"SB Wu","year":"2022","unstructured":"Wu, S. B. et al. MhNet: multi-scale spatio-temporal hierarchical network for real-time wearable fall risk assessment of the elderly. Comput. Biol. Med. 144, 105355 (2022).","journal-title":"Comput. Biol. Med."},{"key":"2175_CR682","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/1534734617739195","volume":"16","author":"H Tchero","year":"2017","unstructured":"Tchero, H. et al. Telemedicine in diabetic foot care: a systematic literature review of interventions and meta-analysis of controlled trials. Int. J. Lower Extrem. Wounds 16, 274\u2013283 (2017).","journal-title":"Int. J. Lower Extrem. Wounds"},{"key":"2175_CR683","doi-asserted-by":"publisher","DOI":"10.2196\/26670","volume":"23","author":"T Song","year":"2021","unstructured":"Song, T. et al. Measuring success of patients\u2019 continuous use of mobile health services for self-management of chronic conditions: model development and validation. J. Med. Internet Res. 23, e26670 (2021).","journal-title":"J. Med. Internet Res."},{"key":"2175_CR684","volume":"32","author":"ROP Lopes","year":"2024","unstructured":"Lopes, R. O. P. et al. Benchmarking mobile applications for the health of people with diabetes mellitus. Rev. Lat. Am. Enferm. 32, e4221 (2024).","journal-title":"Rev. Lat. Am. Enferm."},{"key":"2175_CR685","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jns.12645","volume":"29","author":"AR McDowell","year":"2024","unstructured":"McDowell, A. R. et al. Initial findings using high-resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla. J. Peripher. Nerv. Syst. 29, 368\u2013375 (2024).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2175_CR686","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.15557\/JoU.2020.0013","volume":"20","author":"KP Singh","year":"2020","unstructured":"Singh, K. P., Gupta, K., Kataria, N., Arora, V. & Nagpal, N. High-resolution ultrasonography of the sural nerve in diabetic peripheral neuropathy. J. Ultrason. 20, e83\u2013e89 (2020).","journal-title":"J. Ultrason."},{"key":"2175_CR687","doi-asserted-by":"publisher","first-page":"191","DOI":"10.23736\/S0392-9590.23.05008-3","volume":"42","author":"XY Zhang","year":"2023","unstructured":"Zhang, X. Y. et al. Machine learning models for diabetic neuropathy diagnosis using microcirculatory parameters in type 2 diabetes patients. Int. Angiol. 42, 191\u2013200 (2023).","journal-title":"Int. Angiol."},{"key":"2175_CR688","doi-asserted-by":"publisher","first-page":"102982","DOI":"10.1016\/j.neucli.2024.102982","volume":"54","author":"YR Lai","year":"2024","unstructured":"Lai, Y. R. et al. Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes. Neurophysiol. Clin. 54, 102982 (2024).","journal-title":"Neurophysiol. Clin."},{"key":"2175_CR689","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","volume":"12","author":"B Sheng","year":"2024","unstructured":"Sheng, B. et al. Artificial intelligence for diabetes care: current and future prospects. Lancet Diabetes Endocrinol. 12, 569\u2013595 (2024).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2175_CR690","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.arth.2018.02.067","volume":"33","author":"SA Bini","year":"2018","unstructured":"Bini, S. A. Artificial intelligence, machine learning, deep learning, and cognitive computing: what do these terms mean and how will they impact health care? J. Arthroplast. 33, 2358\u20132361 (2018).","journal-title":"J. Arthroplast."},{"key":"2175_CR691","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-biodatasci-120423-120107","volume":"7","author":"H Cho","year":"2024","unstructured":"Cho, H. et al. Privacy-enhancing technologies in biomedical data science. Annu. Rev. Biomed. Data Sci. 7, 317\u2013343 (2024).","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"2175_CR692","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41746-024-01224-3","volume":"7","author":"LC Zuchowski","year":"2024","unstructured":"Zuchowski, L. C., Zuchowski, M. L. & Nagel, E. A trust based framework for the envelopment of medical AI. NPJ Digit. Med. 7, 230 (2024).","journal-title":"NPJ Digit. Med."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02175-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02175-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T19:01:48Z","timestamp":1745521308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02175-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":692,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02175-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}